{"recordsFiltered":50704,"recordsTotal":50704,"next":"http://fdaaa.trialstracker.net/api/trials/?format=json&length=300&ordering=status&start=43200","previous":"http://fdaaa.trialstracker.net/api/trials/?format=json&length=300&ordering=status&start=42600","results":[{"registry_id":"NCT07377474","publication_url":"https://clinicaltrials.gov/study/NCT07377474","title":"A Study to Investigate the Safety and Effectiveness of the Technolas® TENEO 317 Model 2 Excimer Laser for Laser In Situ Keratomileusis (LASIK) Surgery to Treat Myopia or Myopic Astigmatism With Sphere Between 0.00D and -1.00D","has_exemption":false,"start_date":"2026-04-30","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"Bausch & Lomb Incorporated","sponsor_slug":"bausch-lomb-incorporated","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07523269","publication_url":"https://clinicaltrials.gov/study/NCT07523269","title":"WEARABLE-BP: Wearable Everyday Automated Readings to Enable Assessment of Blood Pressure Control","has_exemption":false,"start_date":"2026-04-30","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"Aktiia SA","sponsor_slug":"aktiia-sa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07555483","publication_url":"https://clinicaltrials.gov/study/NCT07555483","title":"An Open-Label, Multicenter, Randomized, Non-Inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Weekly Doses of Alpha1-Proteinase Inhibitor Subcutaneous (Human) 15% in Patients With Alpha1-Antitrypsin Deficiency Compared to Corresponding Standard 60 mg/kg/Week and 120 mg/kg/Week Doses of Intravenous Alpha1-Proteinase Inhibitor (5%)","has_exemption":false,"start_date":"2026-05-05","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"Grifols Therapeutics LLC","sponsor_slug":"grifols-therapeutics-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07545759","publication_url":"https://clinicaltrials.gov/study/NCT07545759","title":"A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Brenipatide in the Treatment of Adult Participants With IBS-D","has_exemption":false,"start_date":"2026-05-06","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07592689","publication_url":"https://clinicaltrials.gov/study/NCT07592689","title":"A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled, 12-Week Study (Part A) With a 40-Week Open-label Extension (Part B) Evaluating the Efficacy and Safety of Oral DT120 Compared to Placebo in the Treatment of Adults With Major Depressive Disorder - Ascend","has_exemption":false,"start_date":"2026-05-10","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"Definium Therapeutics US, Inc.","sponsor_slug":"definium-therapeutics-us-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07222449","publication_url":"https://clinicaltrials.gov/study/NCT07222449","title":"Wearables-and Blood-based Biomarkers-incorporated Modernisation of Circadian Rhythm Disruption Management in People Living With Alzheimer's Dementia: A Stepwise Study From Digital Inclusivity, Digital Therapy, to Digital Phenotyping and Biomarker Exploration","has_exemption":false,"start_date":"2026-05-11","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"China Medical University Hospital","sponsor_slug":"china-medical-university-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07629557","publication_url":"https://clinicaltrials.gov/study/NCT07629557","title":"Single-arm, Multi-center Study to Evaluate the Safety and Feasibility of Bilateral Epithelium-on Corneal Collagen Cross-linking With Epioxa™ HD/Epioxa™ and UV-A Irradiation Using the O2n™ System and Supplemental Oxygen Using the Boost Goggles® in Subjects With Keratoconus","has_exemption":false,"start_date":"2026-05-11","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"Glaukos Corporation","sponsor_slug":"glaukos-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07604974","publication_url":"https://clinicaltrials.gov/study/NCT07604974","title":"A Phase 2, Open-label Trial Evaluating the Safety, Tolerability and Efficacy of ION775 in Adults With Hypertriglyceridemia","has_exemption":false,"start_date":"2026-05-12","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"Ionis Pharmaceuticals, Inc.","sponsor_slug":"ionis-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07589608","publication_url":"https://clinicaltrials.gov/study/NCT07589608","title":"A Phase 2b, Parallel-Group, Double-Blind, Placebo-Controlled Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight and Without Type 2 Diabetes","has_exemption":false,"start_date":"2026-05-15","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07477691","publication_url":"https://clinicaltrials.gov/study/NCT07477691","title":"A Phase 4 Study of Immune Modulation During Palynziq® Treatment in Adults With Phenylketonuria (PKU)","has_exemption":false,"start_date":"2026-05-29","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"BioMarin Pharmaceutical","sponsor_slug":"biomarin-pharmaceutical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07598708","publication_url":"https://clinicaltrials.gov/study/NCT07598708","title":"A Randomized, Double-blind, 3-Arm Parallel Design Study to Investigate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Cleminorexton Compared With Placebo in Participants With Central Disorders of Hypersomnolence","has_exemption":false,"start_date":"2026-05-29","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"Centessa Pharmaceuticals (UK) Limited","sponsor_slug":"centessa-pharmaceuticals-uk-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07305363","publication_url":"https://clinicaltrials.gov/study/NCT07305363","title":"The SELIC Trial Seladelpar for the Treatment of Ischemic Cholangiopathy: An Open-Label, Single-Arm, Investigator-Initiated Study","has_exemption":false,"start_date":"2026-05-31","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07499440","publication_url":"https://clinicaltrials.gov/study/NCT07499440","title":"Safety and Efficacy of HB-1 for PTSD: A Multi-center, Randomized, Double-Blind, Placebo-Controlled Study","has_exemption":false,"start_date":"2026-06-03","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"HB BioTech, LLC","sponsor_slug":"hb-biotech-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07359820","publication_url":"https://clinicaltrials.gov/study/NCT07359820","title":"A Phase 2, Open-Label, Single-Arm Study of Lirafugratinib in Patients With Previously Treated, Unresectable, Locally Advanced or Metastatic Solid Tumors (Excluding Cholangiocarcinoma) With FGFR2 Fusion or Rearrangement","has_exemption":false,"start_date":"2026-06-04","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"Elevar Therapeutics","sponsor_slug":"elevar-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07671924","publication_url":"https://clinicaltrials.gov/study/NCT07671924","title":"A Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study to Evaluate the Efficacy and Safety of Nalbuphine Extended-Release Tablets for the Treatment of Participants With Refractory Chronic Cough","has_exemption":false,"start_date":"2026-06-22","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"Trevi Therapeutics","sponsor_slug":"trevi-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05731050","publication_url":"https://clinicaltrials.gov/study/NCT05731050","title":"A Phase II, Open Label, Multi Dose Study of NM8074 in Soliris-Treated Subjects With Paroxysmal Nocturnal Hemoglobinuria (PNH)","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"NovelMed Therapeutics","sponsor_slug":"novelmed-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07564596","publication_url":"https://clinicaltrials.gov/study/NCT07564596","title":"A Phase 1b/2a Open-Label, Dose-Escalation and Dose-Expansion Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Budoprutug (TNT119) in Adult Subjects With Systemic Lupus Erythematosus (SLE)","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"Climb Bio, Inc.","sponsor_slug":"climb-bio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07226141","publication_url":"https://clinicaltrials.gov/study/NCT07226141","title":"Valproate for the Treatment of Residual Amblyopia","has_exemption":false,"start_date":"2026-07-01","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"Boston Children’s Hospital","sponsor_slug":"boston-childrens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07453888","publication_url":"https://clinicaltrials.gov/study/NCT07453888","title":"Randomized, Multicenter, Vehicle-Controlled, Double-Masked Phase 3 Study to Evaluate the Efficacy and Safety of Intranasal Cenegermin (Recombinant Human Nerve Growth Factor [rhNGF]) in Adult Participants With Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION)","has_exemption":false,"start_date":"2026-07-01","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"Dompé Farmaceutici S.p.A","sponsor_slug":"dompe-farmaceutici-spa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07704931","publication_url":"https://clinicaltrials.gov/study/NCT07704931","title":"Pilot Study to Evaluate Changes in Intra-Epidermal Nerve Fiber Density (IENFD) in Patients With Small-Fiber Neuropathy","has_exemption":false,"start_date":"2026-07-01","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"TriCity Research Center","sponsor_slug":"tricity-research-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07727057","publication_url":"https://clinicaltrials.gov/study/NCT07727057","title":"Workflow Study of the Dual Energy THERMOCOOL SMARTTOUCH™ SF (DE STSF) Catheter With the TRUPULSE™ Generator for Treatment of Ventricular Arrhythmias (VAs)","has_exemption":false,"start_date":"2026-07-08","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"Biosense Webster, Inc.","sponsor_slug":"biosense-webster-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07759999","publication_url":"https://clinicaltrials.gov/study/NCT07759999","title":"UW26028: Clinical Evaluation of a Treatment Planning Software and Oncology Information System for Proton Therapy","has_exemption":false,"start_date":"2026-07-15","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"University of Wisconsin, Madison","sponsor_slug":"university-of-wisconsin-madison","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03171129","publication_url":"https://clinicaltrials.gov/study/NCT03171129","title":"Adaptive Dynamic Inspiratory Nasal Apparatus (ADINA): Comparison to High Flow Nasal Cannula (HFNC)","has_exemption":false,"start_date":"2026-07-31","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"Loma Linda University","sponsor_slug":"loma-linda-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07457164","publication_url":"https://clinicaltrials.gov/study/NCT07457164","title":"A Phase 2, Open-Label, Single-Arm, Multicentre Study Investigating the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Teverelix DP, a Gonadotropin-releasing Hormone (GnRH) Antagonist, in Patients With Advanced Prostate Cancer","has_exemption":false,"start_date":"2026-07-31","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"Antev Ltd.","sponsor_slug":"antev-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07564102","publication_url":"https://clinicaltrials.gov/study/NCT07564102","title":"dMD-002 US Pilot Study A Single-center, Randomized, Double-blind, Pilot Study to Assess the Efficacy and Safety of dMD-002 in Patients After Radical Prostatectomy","has_exemption":false,"start_date":"2026-08-01","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"Mochida Medical USA, Inc.","sponsor_slug":"mochida-medical-usa-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07130994","publication_url":"https://clinicaltrials.gov/study/NCT07130994","title":"Reduction or Elimination of Mitral Regurgitation With the SATURN Trans-septal TMVR System in Patients With Severe, Symptomatic Mitral Regurgitation (Cassini-US)","has_exemption":false,"start_date":"2026-08-05","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"InnovHeart","sponsor_slug":"innovheart","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07147231","publication_url":"https://clinicaltrials.gov/study/NCT07147231","title":"A Phase 1 and Randomized Phase 2 Trial of Pidnarulex (CX-5461) and Cemiplimab (REGN2810) in Refractory Microsatellite Stable Colorectal Cancer","has_exemption":false,"start_date":"2026-08-10","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07553065","publication_url":"https://clinicaltrials.gov/study/NCT07553065","title":"RELIEVE (RandomizEd triaL of Intravesical xEomin for Incontinence Via the VibE System) - a Randomized, Prospective, Multicenter, Double Blind, Placebo and Sham Controlled Study to Assess the Safety and Efficacy of NT 201 Intravesical Administration Using Vibe System in the Treatment of Female Participants Suffering From Idiopathic Overactive Bladder","has_exemption":false,"start_date":"2026-08-14","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"Vensica Therapeutics Ltd.","sponsor_slug":"vensica-therapeutics-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07674667","publication_url":"https://clinicaltrials.gov/study/NCT07674667","title":"A Randomized, Double-Blind, Placebo-Controlled, Phase 1 / 2 Trial Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Exploratory Efficacy of TRCN-1023 Administered by Intrathecal Injections to Adult People Living With Amyotrophic Lateral Sclerosis","has_exemption":false,"start_date":"2026-08-20","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"Trace Neuroscience, Inc.","sponsor_slug":"trace-neuroscience-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07731178","publication_url":"https://clinicaltrials.gov/study/NCT07731178","title":"Evaluating the Efficacy of Preoperative Cryoneurolysis With Iovera on Postoperative Pain, Function, and Opioid Use Following ACL Reconstruction With Bone-Patellar Tendon-Bone Autograft","has_exemption":false,"start_date":"2026-08-31","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07754526","publication_url":"https://clinicaltrials.gov/study/NCT07754526","title":"A Multicenter, Randomized, Controlled, Open Label Study Comparing Treatment With OCM™️ Plus Compression and Routine Care, to Compression and Routine Care Alone for Venous Leg Ulcers","has_exemption":false,"start_date":"2026-08-31","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"Omeza, LLC","sponsor_slug":"omeza-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07779616","publication_url":"https://clinicaltrials.gov/study/NCT07779616","title":"A Phase 2A, Proof-of-Concept, Randomized, Parallel, Double-Blind, Placebo-Controlled Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of PTC844 in Participants With Active Rheumatoid Arthritis","has_exemption":false,"start_date":"2026-08-31","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"PTC Therapeutics","sponsor_slug":"ptc-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05522426","publication_url":"https://clinicaltrials.gov/study/NCT05522426","title":"Open Label, Multi-Center Study, Evaluating the Effect of Adipose Tissue Processed With the SyntrFuge™ System for Facial Fat Grafting","has_exemption":false,"start_date":"2026-09-01","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"Syntr Health Technologies, Inc.","sponsor_slug":"syntr-health-technologies-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07636434","publication_url":"https://clinicaltrials.gov/study/NCT07636434","title":"My MS Toolkit: An Internet-Based Depression Self-Management Program for Adults Living With Multiple Sclerosis","has_exemption":false,"start_date":"2026-09-01","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07796074","publication_url":"https://clinicaltrials.gov/study/NCT07796074","title":"Anesthetic Greater Occipital Nerve Blockade in Veterans With Post-Traumatic Headache: Sub-study 2","has_exemption":false,"start_date":"2026-09-01","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07831369","publication_url":"https://clinicaltrials.gov/study/NCT07831369","title":"VISTA: Valproic Acid, Irinotecan, and Simvastatin for Recurrent Glioma","has_exemption":false,"start_date":"2026-09-04","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"Inova Health Care Services","sponsor_slug":"inova-health-care-services","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07802119","publication_url":"https://clinicaltrials.gov/study/NCT07802119","title":"Transjugular Approach for Implantation of Active Fixation Leadless Pacemakers: A Feasibility Study","has_exemption":false,"start_date":"2026-09-10","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"Min Shen","sponsor_slug":"min-shen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07807397","publication_url":"https://clinicaltrials.gov/study/NCT07807397","title":"Oral Hygiene Assistance Training Program","has_exemption":false,"start_date":"2026-09-20","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"Colgate Palmolive","sponsor_slug":"colgate-palmolive","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07618299","publication_url":"https://clinicaltrials.gov/study/NCT07618299","title":"Evaluation of the Excretion of Fosfomycin Into Breast Milk Following a Single Intravenous Dose of ZTI-01 (6 g) in Healthy Lactating Women","has_exemption":false,"start_date":"2026-09-22","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"Meitheal Pharmaceuticals, Inc.","sponsor_slug":"meitheal-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07840183","publication_url":"https://clinicaltrials.gov/study/NCT07840183","title":"Epidural Analgesia verSus Opioid-sparing analgEsia Protocol for Pain Control Following Open Ventral Hernia Repair With Transversus Abdominis Release: A Randomized Controlled Trial","has_exemption":false,"start_date":"2026-09-25","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05519501","publication_url":"https://clinicaltrials.gov/study/NCT05519501","title":"Clinical Investigation Evaluating the Effect of Adipose Tissue Processed With the SyntrFuge™ System in the Healing of Diabetic Foot Ulcers","has_exemption":false,"start_date":"2026-09-30","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"Syntr Health Technologies, Inc.","sponsor_slug":"syntr-health-technologies-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06534502","publication_url":"https://clinicaltrials.gov/study/NCT06534502","title":"A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Zonisamide Oral Suspension (100 mg/5 ml) to Determine a Dosing Regimen in Children 1 Month to 17 Years of Age With Partial-onset Seizures","has_exemption":false,"start_date":"2026-09-30","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"Azurity Pharmaceuticals","sponsor_slug":"azurity-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06840496","publication_url":"https://clinicaltrials.gov/study/NCT06840496","title":"A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase 3 Study of Bionetide for the Treatment of Girls and Women With Rett Syndrome","has_exemption":false,"start_date":"2026-09-30","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"Biomed Industries, Inc.","sponsor_slug":"biomed-industries-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07001072","publication_url":"https://clinicaltrials.gov/study/NCT07001072","title":"Mitigating Freezing of Gait (FoG) in Parkinson's Disease With Spatiotemporal Haptic Feedback Delivered by Smartshoes","has_exemption":false,"start_date":"2026-09-30","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07034261","publication_url":"https://clinicaltrials.gov/study/NCT07034261","title":"Continuous Glucose Monitoring to Detect Postpartum Dysglycemia in Patients With Gestational Diabetes","has_exemption":false,"start_date":"2026-09-30","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"University of Chicago","sponsor_slug":"university-of-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07079969","publication_url":"https://clinicaltrials.gov/study/NCT07079969","title":"Effects of Photobiomodulation on Inflammation and Chronic Pain in Knee Osteoarthritis","has_exemption":false,"start_date":"2026-09-30","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07507396","publication_url":"https://clinicaltrials.gov/study/NCT07507396","title":"Non-invasive Temperature Monitoring in Pediatric Intensive Care Patients Requiring Targeted Temperature Management: Evaluation of Temple Touch Pro","has_exemption":false,"start_date":"2026-09-30","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"Medical College of Wisconsin","sponsor_slug":"medical-college-of-wisconsin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07545746","publication_url":"https://clinicaltrials.gov/study/NCT07545746","title":"Adjuvant 5-Fluorouracil Following Thermal Ablation to Improve HPV Treatment Outcomes in Women With HIV in Kenya : The ASCEND Trial","has_exemption":false,"start_date":"2026-09-30","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"UNC Lineberger Comprehensive Cancer Center","sponsor_slug":"unc-lineberger-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07719244","publication_url":"https://clinicaltrials.gov/study/NCT07719244","title":"xDot Access Management System Pivotal Study for Closure of Large Bore Femoral-Arterial & Venous-Access Sites","has_exemption":false,"start_date":"2026-09-30","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"xDot Medical, Inc","sponsor_slug":"xdot-medical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07756359","publication_url":"https://clinicaltrials.gov/study/NCT07756359","title":"Efficacy of the Dual GIP - GLP-1 Receptor Agonist Tirzepatide in Patients With an Ileal Pouch-anal Anastomosis (IPAA) and Chronic High Bowel Frequency (I8F-NS-X008)","has_exemption":false,"start_date":"2026-09-30","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"University of North Carolina, Chapel Hill","sponsor_slug":"university-of-north-carolina-chapel-hill","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07757113","publication_url":"https://clinicaltrials.gov/study/NCT07757113","title":"Comparative Study of Embolic Agents in Patients With Subdural Hemorrhage Undergoing Middle Meningeal Artery (MMA) Embolization","has_exemption":false,"start_date":"2026-09-30","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"Sanford Health","sponsor_slug":"sanford-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07807644","publication_url":"https://clinicaltrials.gov/study/NCT07807644","title":"A Randomized, Double-Blind, Double-Dummy, Placebo- and Active-Controlled, 2-Part Phase 2 Trial to Investigate the Efficacy and Safety of GRT7040 in Adult Participants With Acute Pain Following Bunionectomy","has_exemption":false,"start_date":"2026-09-30","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"Grünenthal GmbH","sponsor_slug":"grunenthal-gmbh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07828834","publication_url":"https://clinicaltrials.gov/study/NCT07828834","title":"A Pilot Single-center Randomized Controlled Trial of Software Guided Point-of-care","has_exemption":false,"start_date":"2026-09-30","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"Corewell Health West","sponsor_slug":"corewell-health-west","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07829419","publication_url":"https://clinicaltrials.gov/study/NCT07829419","title":"Clinical Performance Evaluation of Two Monthly Replacement Silicone Hydrogel Multifocal Toric Lens Designs in Habitual Soft Contact Lens Wearers","has_exemption":false,"start_date":"2026-09-30","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"CooperVision International Limited (CVIL)","sponsor_slug":"coopervision-international-limited-cvil","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07829458","publication_url":"https://clinicaltrials.gov/study/NCT07829458","title":"Remimazolam for Procedural Sedation in Cardiac Patients Undergoing Transesophageal Echocardiogram Procedures","has_exemption":false,"start_date":"2026-09-30","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07850804","publication_url":"https://clinicaltrials.gov/study/NCT07850804","title":"Trial of NASHA Dx Urethral Bulking System to Treat Stress Urinary Incontinence and Stress Predominant Mixed Urinary Incontinence","has_exemption":false,"start_date":"2026-09-30","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"Palette Life Sciences, Inc.","sponsor_slug":"palette-life-sciences-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07853924","publication_url":"https://clinicaltrials.gov/study/NCT07853924","title":"Effect of Intravenous Oxytocin on Post Dural Puncture Headache After Caesarean Sections","has_exemption":false,"start_date":"2026-09-30","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"Assiut University","sponsor_slug":"assiut-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07872982","publication_url":"https://clinicaltrials.gov/study/NCT07872982","title":"Real-time Cerebral Autoregulation Monitoring and Protection of Brain During Cardiac Surgery Requiring Heart-lung Machine (\"BrainProtect\")","has_exemption":false,"start_date":"2026-09-30","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"Scienceforbrain, UAB","sponsor_slug":"scienceforbrain-uab","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07853690","publication_url":"https://clinicaltrials.gov/study/NCT07853690","title":"A Pilot Study Assessing the Safety and Efficacy of Histotripsy as an Adjunctive Treatment for Biliary Tract Cancer","has_exemption":false,"start_date":"2026-10-05","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07852338","publication_url":"https://clinicaltrials.gov/study/NCT07852338","title":"a Randomized Controlled Multicenter Clinical Trial, Evaluating the Efficacy of a Single Layer Placental-based Biologic and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers.","has_exemption":false,"start_date":"2026-10-08","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"Applied Biologics, LLC","sponsor_slug":"applied-biologics-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07301125","publication_url":"https://clinicaltrials.gov/study/NCT07301125","title":"Myofunctional Therapy for Obstructive Sleep Apnea","has_exemption":false,"start_date":"2026-10-23","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"University of Minnesota","sponsor_slug":"university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07194642","publication_url":"https://clinicaltrials.gov/study/NCT07194642","title":"Feasibility and Performance of Continuous Glucose Monitoring to Guide Computerized Insulin Infusion Therapy in Non-ICU Patients Receiving Corticosteroid Therapy and Specialized Nutrition","has_exemption":false,"start_date":"2026-10-30","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"University of Nebraska","sponsor_slug":"university-of-nebraska","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07475091","publication_url":"https://clinicaltrials.gov/study/NCT07475091","title":"Pharyngeal High Resolution Manometry Standardization of Metrics","has_exemption":false,"start_date":"2026-10-31","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"University of Wisconsin, Madison","sponsor_slug":"university-of-wisconsin-madison","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07536282","publication_url":"https://clinicaltrials.gov/study/NCT07536282","title":"A Phase I/IIa, Randomized, Double Blind, Placebo Controlled, Dose Escalation and Cohort Expansion Study to Evaluate the Safety, Tolerability, Immunogenicity, and Efficacy of NWRD09 Injection in Female Participants With Persistent HPV16 Infection","has_exemption":false,"start_date":"2026-10-31","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"Newish Biotech (Wuxi) Co., Ltd.","sponsor_slug":"newish-biotech-wuxi-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07636161","publication_url":"https://clinicaltrials.gov/study/NCT07636161","title":"PLEASURE (Pleasing Lovers, Efficacy, Arousal, Satisfaction, and Uptake Research on Eroxon): A Pilot Randomized Trial of Eroxon® Gel as an Adjunct to Tadalafil in Young Men With Diabetes-Associated Erectile Dysfunction","has_exemption":false,"start_date":"2026-10-31","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07871461","publication_url":"https://clinicaltrials.gov/study/NCT07871461","title":"Utilizing Standard of Care Induction Chemotherapy Followed by MR-LINAC Radiotherapy and Surgical Exploration to Improve Resectability Rates in Potentially Resectable Locally Advanced Pancreatic Cancer","has_exemption":false,"start_date":"2026-10-31","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)","sponsor_slug":"allegheny-singer-research-institute-also-known-as-allegheny-health-network-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07419009","publication_url":"https://clinicaltrials.gov/study/NCT07419009","title":"Evaluating Frontal Pole as a Window to Modulation of Cognitive Control in OCD","has_exemption":false,"start_date":"2026-11-01","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"Dartmouth-Hitchcock Medical Center","sponsor_slug":"dartmouth-hitchcock-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07664527","publication_url":"https://clinicaltrials.gov/study/NCT07664527","title":"A Proof-of-Concept Study of a Novel Method for Removal of Residual Oropharyngeal Inhaled Corticosteroid Deposits in Asthma","has_exemption":false,"start_date":"2026-11-30","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"University of Wisconsin, Madison","sponsor_slug":"university-of-wisconsin-madison","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07883512","publication_url":"https://clinicaltrials.gov/study/NCT07883512","title":"Cardioprotective Effects of Empagliflozin in Breast Cancer Patients Receiving Chemotherapy: A Pilot Study","has_exemption":false,"start_date":"2026-12-01","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"Virginia Commonwealth University","sponsor_slug":"virginia-commonwealth-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06740812","publication_url":"https://clinicaltrials.gov/study/NCT06740812","title":"Broadening Antiemetics Research by Comparing the Effectiveness of Fosaprepitant and Metoclopramide: A Randomized Control Trial","has_exemption":false,"start_date":"2026-12-31","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"Montefiore Medical Center","sponsor_slug":"montefiore-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07487805","publication_url":"https://clinicaltrials.gov/study/NCT07487805","title":"Ivermectin Combined With Immune-Checkpoint Inhibition in Cancer (ICONIC)","has_exemption":false,"start_date":"2026-12-31","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06580444","publication_url":"https://clinicaltrials.gov/study/NCT06580444","title":"Pregnenolone to Target Concurrent Posttraumatic Stress Disorder (PTSD) and Stress Induced Alcohol Use in Veterans: A Dose Finding Study","has_exemption":false,"start_date":"2027-01-15","completion_date":"2027-09-30","has_results":false,"results_due":false,"sponsor_name":"Pharmacotherapies for Alcohol and Substance Use Disorders Alliance","sponsor_slug":"pharmacotherapies-for-alcohol-and-substance-use-disorders-alliance","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03674697","publication_url":"https://clinicaltrials.gov/study/NCT03674697","title":"The Effect of Light Therapy on Post-Surgical Pain","has_exemption":false,"start_date":"2018-09-05","completion_date":"2027-10-01","has_results":false,"results_due":false,"sponsor_name":"University of Arizona","sponsor_slug":"university-of-arizona","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03672773","publication_url":"https://clinicaltrials.gov/study/NCT03672773","title":"A Phase 2 Study of Continuous Talazoparib Plus Intermittent Low-Dose Temozolomide in Patients With Relapsed or Refractory Extensive-Stage Small Cell Lung Cancer (TRIO-US L-07)","has_exemption":false,"start_date":"2018-10-31","completion_date":"2027-10-01","has_results":false,"results_due":false,"sponsor_name":"Jonsson Comprehensive Cancer Center","sponsor_slug":"jonsson-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04025372","publication_url":"https://clinicaltrials.gov/study/NCT04025372","title":"INTREPId (INTermediate Risk Erection PreservatIon Trial): A Randomized Trial of Radiation Therapy and Darolutamide for Prostate Cancer","has_exemption":false,"start_date":"2020-06-01","completion_date":"2027-10-01","has_results":false,"results_due":false,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04210089","publication_url":"https://clinicaltrials.gov/study/NCT04210089","title":"Total Contact Soft Cast in Diabetic Foot Ulcers","has_exemption":false,"start_date":"2020-10-13","completion_date":"2027-10-01","has_results":false,"results_due":false,"sponsor_name":"University of Minnesota","sponsor_slug":"university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04040452","publication_url":"https://clinicaltrials.gov/study/NCT04040452","title":"Continuous Infusion Versus Intermittent Ketorolac for Postoperative Pain Control in Pediatric Cardiac Surgery Patients","has_exemption":false,"start_date":"2021-03-01","completion_date":"2027-10-01","has_results":false,"results_due":false,"sponsor_name":"Phoenix Children's Hospital","sponsor_slug":"phoenix-childrens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04828798","publication_url":"https://clinicaltrials.gov/study/NCT04828798","title":"Directional Versus Nondirectional Deep Brain Stimulation of the VIM Thalamic Nucleus for Essential Tremor: Assessment of Therapeutic Window, Speech, Gait and Balance","has_exemption":false,"start_date":"2021-04-01","completion_date":"2027-10-01","has_results":false,"results_due":false,"sponsor_name":"Oregon Health and Science University","sponsor_slug":"oregon-health-and-science-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04815096","publication_url":"https://clinicaltrials.gov/study/NCT04815096","title":"Imaging Immune Activation in COVID-19","has_exemption":false,"start_date":"2021-04-15","completion_date":"2027-10-01","has_results":false,"results_due":false,"sponsor_name":"CellSight Technologies, Inc.","sponsor_slug":"cellsight-technologies-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05010590","publication_url":"https://clinicaltrials.gov/study/NCT05010590","title":"Anabolic Therapy in Postmenopausal Osteoporosis","has_exemption":false,"start_date":"2022-03-24","completion_date":"2027-10-01","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05415072","publication_url":"https://clinicaltrials.gov/study/NCT05415072","title":"A Phase I/II, Multi-center, Open Label Study of DYP688 in Patients With Metastatic Uveal Melanoma (MUM) and Other GNAQ/11 Mutant Melanomas","has_exemption":false,"start_date":"2022-07-04","completion_date":"2027-10-01","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05068232","publication_url":"https://clinicaltrials.gov/study/NCT05068232","title":"A Phase II Trial of Durvalumab and Ablative Radiation in Extensive-Stage Small Cell Lung Cancer (DARES)","has_exemption":false,"start_date":"2022-08-19","completion_date":"2027-10-01","has_results":false,"results_due":false,"sponsor_name":"University of Chicago","sponsor_slug":"university-of-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05489211","publication_url":"https://clinicaltrials.gov/study/NCT05489211","title":"A Phase II, Multicentre, Open-label, Master Protocol to Evaluate the Efficacy and Safety of Datopotamab Deruxtecan (Dato-DXd) as Monotherapy and in Combination With Anticancer Agents in Patients With Advanced/Metastatic Solid Tumours","has_exemption":false,"start_date":"2022-09-06","completion_date":"2027-10-01","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05531084","publication_url":"https://clinicaltrials.gov/study/NCT05531084","title":"Safety and Effectiveness of Surgeon-Modified Fenestrated and Branched Endografts in Treating Subjects With Complex Aortic Aneurysms","has_exemption":false,"start_date":"2022-10-01","completion_date":"2027-10-01","has_results":false,"results_due":false,"sponsor_name":"Jesse Manunga, MD","sponsor_slug":"jesse-manunga-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05361720","publication_url":"https://clinicaltrials.gov/study/NCT05361720","title":"Optimal Treatment by Invoking Biologic Clusters in Renal Cell Carcinoma (OPTIC RCC)","has_exemption":false,"start_date":"2022-12-06","completion_date":"2027-10-01","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt-Ingram Cancer Center","sponsor_slug":"vanderbilt-ingram-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05370820","publication_url":"https://clinicaltrials.gov/study/NCT05370820","title":"Prevention of Postpartum Hemorrhage: Pharmacokinetics (PK) Abd Pharmacodynamics (PD) of Tranexamic Acid","has_exemption":false,"start_date":"2022-12-28","completion_date":"2027-10-01","has_results":false,"results_due":false,"sponsor_name":"Inova Health Care Services","sponsor_slug":"inova-health-care-services","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04789044","publication_url":"https://clinicaltrials.gov/study/NCT04789044","title":"A Phase 2a Multicenter Randomized Controlled Trial Evaluating the Safety and Efficacy of Polyethylene Glycol (PEG) Mediated Fusion (PEG Fusion) Compared to Standard of Care in the Repair of Mixed Motor-sensory Acute Peripheral Nerve Injuries (PNI) for Rapid and Immediate Improvement in Outcome","has_exemption":false,"start_date":"2023-06-01","completion_date":"2027-10-01","has_results":false,"results_due":false,"sponsor_name":"Major Extremity Trauma Research Consortium","sponsor_slug":"major-extremity-trauma-research-consortium","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05819138","publication_url":"https://clinicaltrials.gov/study/NCT05819138","title":"Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes","has_exemption":false,"start_date":"2023-06-21","completion_date":"2027-10-01","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05838560","publication_url":"https://clinicaltrials.gov/study/NCT05838560","title":"Dasatinib Plus Quercetin for Accelerated Aging in Mental Disorders","has_exemption":false,"start_date":"2023-07-01","completion_date":"2027-10-01","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05850234","publication_url":"https://clinicaltrials.gov/study/NCT05850234","title":"A Phase Ib/II Study of AZD0120, Dual-Targeting Autologous Chimeric Antigen Receptor T-cell (CAR T) Therapy Directed Against CD19 and B-cell Maturation Antigen (BCMA) in Participants With Relapsed/Refractory Multiple Myeloma (DURGA-1)","has_exemption":false,"start_date":"2023-07-20","completion_date":"2027-10-01","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05996900","publication_url":"https://clinicaltrials.gov/study/NCT05996900","title":"Investigating the Neural Mechanisms of Repetitive Brain Stimulation With Invasive and Noninvasive Electrophysiology in Humans","has_exemption":false,"start_date":"2023-09-01","completion_date":"2027-10-01","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06047080","publication_url":"https://clinicaltrials.gov/study/NCT06047080","title":"A Phase III, Multicenter, Randomized, Open-Label Study Comparing the Efficacy and Safety of Glofitamab (RO7082859) in Combination With Polatuzumab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (Pola-R-CHP) Versus Pola-R-CHP in Previously Untreated Patients With Large B-Cell Lymphoma","has_exemption":false,"start_date":"2023-09-18","completion_date":"2027-10-01","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06065462","publication_url":"https://clinicaltrials.gov/study/NCT06065462","title":"Safety and Efficacy of Targeting PP2A in Ovarian Clear Cell Carcinoma Using Dostarlimab and LB-100","has_exemption":false,"start_date":"2023-11-10","completion_date":"2027-10-01","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05950945","publication_url":"https://clinicaltrials.gov/study/NCT05950945","title":"A Phase 3b, Multicenter, Global, Interventional, Open-label Study of Trastuzumab Deruxtecan (T-DXd), an Anti-HER2-Antibody Drug Conjugate (ADC), in Subjects Who Have Unresectable and/or Metastatic HER2-low or HER2 Immunohistochemistry (IHC) 0 Breast Cancer (DESTINY-Breast15)","has_exemption":false,"start_date":"2023-12-30","completion_date":"2027-10-01","has_results":false,"results_due":false,"sponsor_name":"Daiichi Sankyo","sponsor_slug":"daiichi-sankyo","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05977439","publication_url":"https://clinicaltrials.gov/study/NCT05977439","title":"A Multiphase Program of Multimodal Computational Modeling and Hybrid Interventions Including EEG-Synchronized Transcranial Magnetic Stimulation and Cognitive Behavioral Therapy","has_exemption":false,"start_date":"2024-02-01","completion_date":"2027-10-01","has_results":false,"results_due":false,"sponsor_name":"Medical University of South Carolina","sponsor_slug":"medical-university-of-south-carolina","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06235801","publication_url":"https://clinicaltrials.gov/study/NCT06235801","title":"A Phase I/II Study of Gilteritinib and Momelotinib for Patients With Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia","has_exemption":false,"start_date":"2024-05-22","completion_date":"2027-10-01","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06449326","publication_url":"https://clinicaltrials.gov/study/NCT06449326","title":"Multimodal Image Analysis and Guidance of Neuromodulation for Trauma-Related Symptoms","has_exemption":false,"start_date":"2024-06-01","completion_date":"2027-10-01","has_results":false,"results_due":false,"sponsor_name":"University of New Mexico","sponsor_slug":"university-of-new-mexico","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06429176","publication_url":"https://clinicaltrials.gov/study/NCT06429176","title":"A Phase 2a, Randomized, Placebo-Controlled, Double Blind Multiple Ascending Dose Study in Patients With Cystic Fibrosis Carrying the 3849 +10 Kb C->T Mutation to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPL84","has_exemption":false,"start_date":"2024-06-24","completion_date":"2027-10-01","has_results":false,"results_due":false,"sponsor_name":"SpliSense Ltd.","sponsor_slug":"splisense-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06891807","publication_url":"https://clinicaltrials.gov/study/NCT06891807","title":"RobAR Study: Comparison of Image Based Robotic TKA vs Imageless Augmented Reality-Assisted TKA","has_exemption":false,"start_date":"2024-07-18","completion_date":"2027-10-01","has_results":false,"results_due":false,"sponsor_name":"Medisch Centrum Latem","sponsor_slug":"medisch-centrum-latem","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06567821","publication_url":"https://clinicaltrials.gov/study/NCT06567821","title":"Using Navigation to Improve Accuracy of Maxillary Balloon Sinusotomy","has_exemption":false,"start_date":"2024-09-04","completion_date":"2027-10-01","has_results":false,"results_due":false,"sponsor_name":"Cedars-Sinai Medical Center","sponsor_slug":"cedars-sinai-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05947955","publication_url":"https://clinicaltrials.gov/study/NCT05947955","title":"A Phase 2 Randomized Double-blind Placebo-controlled Study To Evaluate The Efficacy And Safety Of Adjunctive Recombinant Human Plasma Gelsolin With Standard Care For Moderate-to-Severe ARDS Due To Pneumonia Or Other Infections","has_exemption":false,"start_date":"2024-10-03","completion_date":"2027-10-01","has_results":false,"results_due":false,"sponsor_name":"BioAegis Therapeutics Inc.","sponsor_slug":"bioaegis-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06668194","publication_url":"https://clinicaltrials.gov/study/NCT06668194","title":"A Randomized Clinical Trial Comparing the Effect of Force Magnitude on the Rate of Canine Retraction and Gingival Crevicular Fluid Proteome Profile","has_exemption":false,"start_date":"2024-11-13","completion_date":"2027-10-01","has_results":false,"results_due":false,"sponsor_name":"UConn Health","sponsor_slug":"uconn-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06526104","publication_url":"https://clinicaltrials.gov/study/NCT06526104","title":"Phase II Single Arm Study of Tremelimumab and Durvalumab (MEDI4736) (T300+D) in Advanced Hepatocellular Carcinomas With Child-Pugh-B Cirrhosis (STRIDE in CP-B)","has_exemption":false,"start_date":"2024-12-02","completion_date":"2027-10-01","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center at San Antonio","sponsor_slug":"the-university-of-texas-health-science-center-at-san-antonio","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06679140","publication_url":"https://clinicaltrials.gov/study/NCT06679140","title":"AN INTERVENTIONAL EFFICACY AND SAFETY, PHASE 3, DOUBLE-BLIND, 2-ARM STUDY TO INVESTIGATE ORALLY ADMINISTERED IBUZATRELVIR COMPARED WITH PLACEBO IN NON-HOSPITALIZED SYMPTOMATIC ADULT AND ADOLESCENT PARTICIPANTS WITH COVID-19 WHO ARE AT HIGH RISK OF PROGRESSING TO SEVERE ILLNESS","has_exemption":false,"start_date":"2024-12-08","completion_date":"2027-10-01","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05726292","publication_url":"https://clinicaltrials.gov/study/NCT05726292","title":"A Randomized Phase II Trial of Neoadjuvant Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer","has_exemption":false,"start_date":"2025-01-06","completion_date":"2027-10-01","has_results":false,"results_due":false,"sponsor_name":"University of Chicago","sponsor_slug":"university-of-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06479824","publication_url":"https://clinicaltrials.gov/study/NCT06479824","title":"NHLBI and Cook Trans-Atrial Intra-Pericardial Tricuspid Annuloplasty (TRAIPTA) Early Feasibility Study","has_exemption":false,"start_date":"2025-08-19","completion_date":"2027-10-01","has_results":false,"results_due":false,"sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","sponsor_slug":"national-heart-lung-and-blood-institute-nhlbi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06961383","publication_url":"https://clinicaltrials.gov/study/NCT06961383","title":"A Double Blind, Randomized, Placebo Controlled Phase 2b Study to Evaluate the Safety and Clinical Efficacy of Treatment With the Autologous Cell Therapy Product, NG01, in Patients With Secondary Progressive Multiple Sclerosis","has_exemption":false,"start_date":"2025-10-01","completion_date":"2027-10-01","has_results":false,"results_due":false,"sponsor_name":"NeuroGenesis Ltd.","sponsor_slug":"neurogenesis-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07210775","publication_url":"https://clinicaltrials.gov/study/NCT07210775","title":"Topical Imiquimod for the Treatment of Oral Dysplastic Lesions With Clinical and Histologic Assessments","has_exemption":false,"start_date":"2025-10-01","completion_date":"2027-10-01","has_results":false,"results_due":false,"sponsor_name":"University of Southern California","sponsor_slug":"university-of-southern-california","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07174453","publication_url":"https://clinicaltrials.gov/study/NCT07174453","title":"A Late Phase Randomized Open-Label Multi Cohort Trial to Evaluate irAEs With Different Standard of Care Dosing Strategies of Standard of Care Immunotherapies","has_exemption":false,"start_date":"2025-10-07","completion_date":"2027-10-01","has_results":false,"results_due":false,"sponsor_name":"University of Kansas Medical Center","sponsor_slug":"university-of-kansas-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07185724","publication_url":"https://clinicaltrials.gov/study/NCT07185724","title":"Balancing Comfort and Success: Post-retrieval Ketorolac in Fresh Embryo Transfers","has_exemption":false,"start_date":"2025-11-08","completion_date":"2027-10-01","has_results":false,"results_due":false,"sponsor_name":"Jessica D. Kresowik","sponsor_slug":"jessica-d-kresowik","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07123090","publication_url":"https://clinicaltrials.gov/study/NCT07123090","title":"A Phase 2 Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell Carcinoma - SPARCC","has_exemption":false,"start_date":"2025-11-24","completion_date":"2027-10-01","has_results":false,"results_due":false,"sponsor_name":"Stephanie Berg","sponsor_slug":"stephanie-berg","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07049458","publication_url":"https://clinicaltrials.gov/study/NCT07049458","title":"A Phase I/IIa, Open-Label, Dose-Escalation and Cohort-Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of CHO-A04 in Subjects With Advanced Solid Tumors","has_exemption":false,"start_date":"2025-12-01","completion_date":"2027-10-01","has_results":false,"results_due":false,"sponsor_name":"Cho Pharma Inc.","sponsor_slug":"cho-pharma-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06041503","publication_url":"https://clinicaltrials.gov/study/NCT06041503","title":"A Phase II Multicenter Study of Enfortumab Vedotin With or Without Pembrolizumab in Rare Genitourinary Tumors (E-VIRTUE)","has_exemption":false,"start_date":"2026-01-20","completion_date":"2027-10-01","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06735820","publication_url":"https://clinicaltrials.gov/study/NCT06735820","title":"Early Phase Study to Evaluate the MEK Inhibitor Selumetinib With the MDM2 Inhibitor APG-115 in Patients With Neurofibromatosis Type 1 and Pre-malignant and Malignant Peripheral Nerve Sheath Tumors","has_exemption":false,"start_date":"2026-06-01","completion_date":"2027-10-01","has_results":false,"results_due":false,"sponsor_name":"AeRang Kim","sponsor_slug":"aerang-kim","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06997198","publication_url":"https://clinicaltrials.gov/study/NCT06997198","title":"Identification, Assessment, and Treatment of Tardive Dyskinesia With Deutetrabenazine in Adults With Intellectual/Developmental Disabilities and Co-occurring Psychiatric and/or Behavioral Disorders","has_exemption":false,"start_date":"2026-06-22","completion_date":"2027-10-01","has_results":false,"results_due":false,"sponsor_name":"University Hospitals Cleveland Medical Center","sponsor_slug":"university-hospitals-cleveland-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07362082","publication_url":"https://clinicaltrials.gov/study/NCT07362082","title":"A Randomized Clinical Trial of Telehealth Treatment for Opioid Use Disorders","has_exemption":false,"start_date":"2026-09-11","completion_date":"2027-10-01","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07497620","publication_url":"https://clinicaltrials.gov/study/NCT07497620","title":"Bimzelx (Bimekizumab) For The Treatment Of Adult Onset Pityriasis Rubra Pilaris: A Single Arm, Open Label, Exploratory Trial","has_exemption":false,"start_date":"2026-10-01","completion_date":"2027-10-01","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07798414","publication_url":"https://clinicaltrials.gov/study/NCT07798414","title":"Randomized Clinical Trial of the Application of TrachPhone HME and the Impact on Patient Satisfaction for Tracheostomized Head and Neck Cancer Patients","has_exemption":false,"start_date":"2026-10-01","completion_date":"2027-10-01","has_results":false,"results_due":false,"sponsor_name":"University of South Florida","sponsor_slug":"university-of-south-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07795827","publication_url":"https://clinicaltrials.gov/study/NCT07795827","title":"Project Suzetrigine: The Efficacy and Safety of Suzetrigine (Journavx™) Following Total Ankle Arthroplasty: an Exploratory Prospective Cohort Study","has_exemption":false,"start_date":"2026-10-01","completion_date":"2027-10-01","has_results":false,"results_due":false,"sponsor_name":"Soheil Ashkani Esfahani","sponsor_slug":"soheil-ashkani-esfahani","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07849465","publication_url":"https://clinicaltrials.gov/study/NCT07849465","title":"Neuroinflammatory and Neuroinjury Biomarker Dynamics Following Hyperbaric Oxygen Therapy in Veterans With Traumatic Brain Injury and Persistent Post-Concussive Symptoms","has_exemption":false,"start_date":"2026-10-01","completion_date":"2027-10-01","has_results":false,"results_due":false,"sponsor_name":"Summit Hyperbarics and Wellness","sponsor_slug":"summit-hyperbarics-and-wellness","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04561206","publication_url":"https://clinicaltrials.gov/study/NCT04561206","title":"A Phase 2 Study of Brentuximab Vedotin Plus Nivolumab Without Stem Cell Consolidation in Patients With Relapsed/Refractory Classical Hodgkin Lymphoma","has_exemption":false,"start_date":"2021-11-12","completion_date":"2027-10-02","has_results":false,"results_due":false,"sponsor_name":"City of Hope Medical Center","sponsor_slug":"city-of-hope-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05404945","publication_url":"https://clinicaltrials.gov/study/NCT05404945","title":"Fitness-adapted, Pembrolizumab-based Therapy for Untreated Classical Hodgkin Lymphoma Patients 60 Years of Age and Above (cHL 001)","has_exemption":false,"start_date":"2022-07-26","completion_date":"2027-10-03","has_results":false,"results_due":false,"sponsor_name":"University of Virginia","sponsor_slug":"university-of-virginia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06562543","publication_url":"https://clinicaltrials.gov/study/NCT06562543","title":"A Single Arm Phase 4 Trial to Evaluate the Safety and Efficacy of Oral Fruquintinib in the Treatment of Refractory Metastatic Colorectal Cancer in Patients From Minority Populations Underrepresented in Prior Fruquintinib Studies","has_exemption":false,"start_date":"2025-01-14","completion_date":"2027-10-04","has_results":false,"results_due":false,"sponsor_name":"Takeda","sponsor_slug":"takeda","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06824987","publication_url":"https://clinicaltrials.gov/study/NCT06824987","title":"Phase 2b Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Dose-Ranging Study to Assess the Efficacy, Safety, and Tolerability of AZD2373 in Participants With APOL1-Mediated Kidney Disease (APPRECIATE)","has_exemption":false,"start_date":"2025-03-05","completion_date":"2027-10-04","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07668388","publication_url":"https://clinicaltrials.gov/study/NCT07668388","title":"Efficacy and Safety of Once-weekly Subcutaneous UBT251 in Participants With Type 2 Diabetes - a Dose-finding Study","has_exemption":false,"start_date":"2026-06-22","completion_date":"2027-10-04","has_results":false,"results_due":false,"sponsor_name":"Novo Nordisk A/S","sponsor_slug":"novo-nordisk-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07099625","publication_url":"https://clinicaltrials.gov/study/NCT07099625","title":"Optimization of Adaptive Rowing Seating (OARS)","has_exemption":false,"start_date":"2026-10-05","completion_date":"2027-10-04","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06540144","publication_url":"https://clinicaltrials.gov/study/NCT06540144","title":"An Open-label Extension Study to Evaluate Rozanolixizumab in Pediatric Study Participants With Generalized Myasthenia Gravis","has_exemption":false,"start_date":"2024-10-08","completion_date":"2027-10-05","has_results":false,"results_due":false,"sponsor_name":"UCB Biopharma SRL","sponsor_slug":"ucb-biopharma-srl","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07091630","publication_url":"https://clinicaltrials.gov/study/NCT07091630","title":"A Phase 3, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating the Efficacy and Safety of Empasiprubart IV in Adults With Chronic Inflammatory Demyelinating Polyneuropathy","has_exemption":false,"start_date":"2025-09-16","completion_date":"2027-10-07","has_results":false,"results_due":false,"sponsor_name":"argenx","sponsor_slug":"argenx","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07125664","publication_url":"https://clinicaltrials.gov/study/NCT07125664","title":"A Two-center, Randomized, Double-blind, Placebo-controlled Study of Intravenous Plasma-purified Alpha-1 Antitrypsin for Hospitalized Patients With COPD Exacerbations (AECOPD Study)","has_exemption":false,"start_date":"2025-10-01","completion_date":"2027-10-07","has_results":false,"results_due":false,"sponsor_name":"Fondazione IRCCS Policlinico San Matteo di Pavia","sponsor_slug":"fondazione-irccs-policlinico-san-matteo-di-pavia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05090358","publication_url":"https://clinicaltrials.gov/study/NCT05090358","title":"Targeting Insulin Feedback to Enhance Alpelisib (TIFA): A Phase 2 Randomized Control Trial in Metastatic PIK3CA-mutant Hormone-Receptor Positive Breast Cancer","has_exemption":false,"start_date":"2021-10-08","completion_date":"2027-10-08","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06751329","publication_url":"https://clinicaltrials.gov/study/NCT06751329","title":"A Phase I/IIa, Multicenter, Open-label, First-in-Human, Dose Escalation and Expansion Study of DM002 in Patients With Advanced Solid Tumors","has_exemption":false,"start_date":"2025-02-17","completion_date":"2027-10-08","has_results":false,"results_due":false,"sponsor_name":"Xadcera Biopharmaceutical (Suzhou) Co., Ltd.","sponsor_slug":"xadcera-biopharmaceutical-suzhou-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07881809","publication_url":"https://clinicaltrials.gov/study/NCT07881809","title":"A Phase 2, Double-Blinded, Randomized, Placebo-Controlled Trial of Ixazomib to Reactivate HIV and Reduce HIV Reservoir Size","has_exemption":false,"start_date":"2026-11-23","completion_date":"2027-10-08","has_results":false,"results_due":false,"sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","sponsor_slug":"national-institute-of-allergy-and-infectious-diseases-niaid","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04153292","publication_url":"https://clinicaltrials.gov/study/NCT04153292","title":"SAPIEN M3 System Transcatheter Mitral Valve Replacement Via Transseptal Access","has_exemption":false,"start_date":"2020-11-12","completion_date":"2027-10-10","has_results":false,"results_due":false,"sponsor_name":"Edwards Lifesciences","sponsor_slug":"edwards-lifesciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07671157","publication_url":"https://clinicaltrials.gov/study/NCT07671157","title":"Phase 2 Open Label Trial of Delgocitinib 20 mg/g Cream in Subjects With Frontal Fibrosing Alopecia (FFA)","has_exemption":false,"start_date":"2026-09-10","completion_date":"2027-10-10","has_results":false,"results_due":false,"sponsor_name":"Maryanne Makredes Senna","sponsor_slug":"maryanne-makredes-senna","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06504459","publication_url":"https://clinicaltrials.gov/study/NCT06504459","title":"A Phase II Study of Venetoclax (ABT-199) in Combination With Cladribine and Low-Dose Cytarabine Alternating With Azacitidine Plus Venetoclax in Newly Diagnosed Monocytic AML and Active-Signaling Mutated AML","has_exemption":false,"start_date":"2025-01-03","completion_date":"2027-10-11","has_results":false,"results_due":false,"sponsor_name":"OHSU Knight Cancer Institute","sponsor_slug":"ohsu-knight-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06744647","publication_url":"https://clinicaltrials.gov/study/NCT06744647","title":"A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate Efficacy and Safety of ALXN2030 in Adult Patients With Antibody-Mediated Rejection After Kidney Transplantation","has_exemption":false,"start_date":"2025-03-07","completion_date":"2027-10-11","has_results":false,"results_due":false,"sponsor_name":"Alexion Pharmaceuticals, Inc.","sponsor_slug":"alexion-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06524960","publication_url":"https://clinicaltrials.gov/study/NCT06524960","title":"A Phase 1/2 Prospective, Randomized, Double-blind, Placebo-controlled Multi-center Clinical Trial to Determine the Safety and Efficacy of Denosumab in Improving Beta Cell Function and Glycemic Control Among Patients With Type 1 Diabetes","has_exemption":false,"start_date":"2025-05-05","completion_date":"2027-10-11","has_results":false,"results_due":false,"sponsor_name":"City of Hope Medical Center","sponsor_slug":"city-of-hope-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07160608","publication_url":"https://clinicaltrials.gov/study/NCT07160608","title":"Phase 2, Randomized, Double-Blind, Placebo-controlled, Parallel-Group, Multicenter Study to Evaluate the Safety and Efficacy of Tarperprumig in Adult Participants With Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (I TRANSCEND)","has_exemption":false,"start_date":"2025-11-26","completion_date":"2027-10-11","has_results":false,"results_due":false,"sponsor_name":"Alexion Pharmaceuticals, Inc.","sponsor_slug":"alexion-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07609940","publication_url":"https://clinicaltrials.gov/study/NCT07609940","title":"A Phase 4, Single-Arm, Multicenter Study of Prophylactic Tocilizumab in Participants With Relapsed/Refractory Multiple Myeloma Treated With Linvoseltamab in the Outpatient Setting","has_exemption":false,"start_date":"2026-07-15","completion_date":"2027-10-11","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07108283","publication_url":"https://clinicaltrials.gov/study/NCT07108283","title":"A Phase 2, Multicenter, Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging Trial to Evaluate the Efficacy and Safety of Zasocitinib in Participants With Nonsegmental Vitiligo","has_exemption":false,"start_date":"2025-11-03","completion_date":"2027-10-12","has_results":false,"results_due":false,"sponsor_name":"Takeda","sponsor_slug":"takeda","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07400653","publication_url":"https://clinicaltrials.gov/study/NCT07400653","title":"EVALUATING THE EFFICACY AND SAFETY OF MET097, A FULLY-BIASED ULTRA LONG-ACTING GLP-1RA, IN PEOPLE WITH OVERWEIGHT OR OBESITY AND TYPE 2 DIABETES: A PHASE 3, MULTI-CENTER RANDOMIZED PLACEBO-CONTROLLED TRIAL (VESPER-5)","has_exemption":false,"start_date":"2026-02-24","completion_date":"2027-10-12","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07614984","publication_url":"https://clinicaltrials.gov/study/NCT07614984","title":"A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of MK-7262 as Monotherapy and When Coadministered With Enlicitide Decanoate in Adults With Elevated Lipoprotein(a)","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-10-12","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06307665","publication_url":"https://clinicaltrials.gov/study/NCT06307665","title":"A Randomized, Double-blind, Multicenter, Parallel-group, Phase IIIb 52 Week Study Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered as Needed in Participants 12 to < 18 Years of Age With Asthma (ACADIA)","has_exemption":false,"start_date":"2024-05-20","completion_date":"2027-10-13","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07215234","publication_url":"https://clinicaltrials.gov/study/NCT07215234","title":"A Phase 1/2, Study to Evaluate the Safety, Tolerability, and Efficacy of One-time Intravitreal Dose of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration","has_exemption":false,"start_date":"2025-10-09","completion_date":"2027-10-13","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07237100","publication_url":"https://clinicaltrials.gov/study/NCT07237100","title":"A Pilot Study of Mirdametinib in Patients With Advanced Melanoma With an NF1 Mutation","has_exemption":false,"start_date":"2025-10-13","completion_date":"2027-10-13","has_results":false,"results_due":false,"sponsor_name":"Kevin Kim, MD","sponsor_slug":"kevin-kim-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06701903","publication_url":"https://clinicaltrials.gov/study/NCT06701903","title":"A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety, and Tolerability of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder Who Have Had Inadequate Response to Generalized Anxiety Disorder Treatment","has_exemption":false,"start_date":"2024-11-21","completion_date":"2027-10-14","has_results":false,"results_due":false,"sponsor_name":"Intra-Cellular Therapies, Inc.","sponsor_slug":"intra-cellular-therapies-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04243499","publication_url":"https://clinicaltrials.gov/study/NCT04243499","title":"A First-in-human, Two-part Clinical Study to Assess the Safety, Tolerability and Activity of IV Doses of ICT01 as Monotherapy and in Combination With a Checkpoint Inhibitor, in Patients With Advanced-stage, Relapsed/Refractory Cancer","has_exemption":false,"start_date":"2020-03-05","completion_date":"2027-10-15","has_results":false,"results_due":false,"sponsor_name":"ImCheck Therapeutics, an Ipsen company","sponsor_slug":"imcheck-therapeutics-an-ipsen-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04850599","publication_url":"https://clinicaltrials.gov/study/NCT04850599","title":"A Single-Arm Phase II Study of Isatuximab With Carfilzomib and Pomalidomide in Relapsed or Refractory Multiple Myeloma","has_exemption":false,"start_date":"2022-06-14","completion_date":"2027-10-15","has_results":false,"results_due":false,"sponsor_name":"OHSU Knight Cancer Institute","sponsor_slug":"ohsu-knight-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05907057","publication_url":"https://clinicaltrials.gov/study/NCT05907057","title":"A Single Arm, Open-label Phase 3b Study to Describe the Safety and Tolerability of Ivosidenib in Combination With Azacitidine in Adult Patients Newly Diagnosed With IDH1m Acute Myeloid Leukemia (AML) Ineligible for Intensive Induction Chemotherapy","has_exemption":false,"start_date":"2023-06-14","completion_date":"2027-10-15","has_results":false,"results_due":false,"sponsor_name":"Servier Affaires Médicales","sponsor_slug":"servier-affaires-medicales","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05922930","publication_url":"https://clinicaltrials.gov/study/NCT05922930","title":"Phase I/II Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells Delivered Intraperitoneally for the Management of Platinum Resistant Ovarian Cancer, Mesonephric-like Adenocarcinoma, and Pancreatic Cancer","has_exemption":false,"start_date":"2023-10-11","completion_date":"2027-10-15","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07044336","publication_url":"https://clinicaltrials.gov/study/NCT07044336","title":"Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4 Selected Advanced/Metastatic Endometrial Cancer Who Progressed On or After Platinum Based Chemotherapy and Anti-PD-1/Anti-PD-L1 Therapy (Bluestar-Endometrial01)","has_exemption":false,"start_date":"2025-08-01","completion_date":"2027-10-15","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07162194","publication_url":"https://clinicaltrials.gov/study/NCT07162194","title":"PRIMER (Prostate MRI With Machine LEarning vs. Radiologist) A Novel MRI-Based Machine Learning Approach vs Radiologist MRI Reading for Targeted Prostate Biopsy: A Non-Inferiority, Within-Person Randomized Controlled Trial for Prostate Cancer Detection","has_exemption":false,"start_date":"2025-09-19","completion_date":"2027-10-15","has_results":false,"results_due":false,"sponsor_name":"University of Southern California","sponsor_slug":"university-of-southern-california","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07287397","publication_url":"https://clinicaltrials.gov/study/NCT07287397","title":"Phase 1/2 Investigation of Novel Experimental Regimen in Amyotrophic Lateral Sclerosis (Pioneer-ALS): An Open-Label, Uncontrolled, Multicenter Study to Assess the Safety and Tolerability of Two Doses of VTx-002","has_exemption":false,"start_date":"2025-12-19","completion_date":"2027-10-15","has_results":false,"results_due":false,"sponsor_name":"Vector Y Therapeutics","sponsor_slug":"vector-y-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07222852","publication_url":"https://clinicaltrials.gov/study/NCT07222852","title":"Cardiovascular Protection After Preeclampsia With Enalapril","has_exemption":false,"start_date":"2026-01-01","completion_date":"2027-10-15","has_results":false,"results_due":false,"sponsor_name":"Women and Infants Hospital of Rhode Island","sponsor_slug":"women-and-infants-hospital-of-rhode-island","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07604662","publication_url":"https://clinicaltrials.gov/study/NCT07604662","title":"Prediction of Acute Kidney Injury (AKI) After Surgery: A Pragmatic Three-Arm Cluster-Randomized Trial","has_exemption":false,"start_date":"2026-10-15","completion_date":"2027-10-15","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07868900","publication_url":"https://clinicaltrials.gov/study/NCT07868900","title":"A Randomized Controlled Trial to Evaluate Wound Complications After Primary Total Hip Arthroplasty Using Silk Fibroin Versus 2-octyl Cyanoacrylate Mesh","has_exemption":false,"start_date":"2026-10-15","completion_date":"2027-10-15","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05159453","publication_url":"https://clinicaltrials.gov/study/NCT05159453","title":"A Randomised, Multiple-Dose, Single Period, Phase II/III Dose Response Study to Examine Transdermal Human Insulin in Adult Diabetic Patients","has_exemption":false,"start_date":"2027-09-02","completion_date":"2027-10-15","has_results":false,"results_due":false,"sponsor_name":"Transdermal Delivery Solutions Corp","sponsor_slug":"transdermal-delivery-solutions-corp","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06112314","publication_url":"https://clinicaltrials.gov/study/NCT06112314","title":"A Phase 3 Randomized, Controlled Study of IMC-F106C Plus Nivolumab Versus Nivolumab Regimens in HLA-A*02:01-Positive Participants With Previously Untreated Advanced Melanoma (PRISM-MEL-301","has_exemption":false,"start_date":"2024-06-05","completion_date":"2027-10-16","has_results":false,"results_due":false,"sponsor_name":"Immunocore Ltd","sponsor_slug":"immunocore-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07858656","publication_url":"https://clinicaltrials.gov/study/NCT07858656","title":"The Impact of Vagus Nerve Stimulation on Improving Sleep for Individuals in an Inpatient Rehab Facility for Post-Acute Ischemic Stroke","has_exemption":false,"start_date":"2026-10-16","completion_date":"2027-10-16","has_results":false,"results_due":false,"sponsor_name":"Casa Colina Hospital and Centers for Healthcare","sponsor_slug":"casa-colina-hospital-and-centers-for-healthcare","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04747613","publication_url":"https://clinicaltrials.gov/study/NCT04747613","title":"An Open Label, Multicenter Roll-over Extension Program (REP) to Characterize the Long-term Safety and Tolerability of Iptacopan (LNP023) in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Have Completed PNH Phase 2 and Phase3 Studies With Iptacopan","has_exemption":false,"start_date":"2021-07-27","completion_date":"2027-10-18","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07071623","publication_url":"https://clinicaltrials.gov/study/NCT07071623","title":"A Phase 3, Randomized, Active-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy and Safety of MK-8527 Oral Once-Monthly as HIV-1 Preexposure Prophylaxis in Women","has_exemption":false,"start_date":"2025-11-10","completion_date":"2027-10-18","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07227012","publication_url":"https://clinicaltrials.gov/study/NCT07227012","title":"AN INTERVENTIONAL OPEN-LABEL PHASE 1B/2 STUDY TO EVALUATE SAFETY, PHARMACOKINETICS, AND PRELIMINARY EFFICACY OF PF-08634404 AS MONOTHERAPY AND COMBINATION THERAPY IN ADULT PARTICIPANTS WITH UNRESECTABLE LOCALLY ADVANCED OR METASTATIC HEPATOCELLULAR CARCINOMA","has_exemption":false,"start_date":"2025-12-01","completion_date":"2027-10-18","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07723924","publication_url":"https://clinicaltrials.gov/study/NCT07723924","title":"A Phase 2b, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of the Efficacy and Safety of Plecanatide in Children and Adolescents Age 6 to <18 Years of Age With Functional Constipation (FC)","has_exemption":false,"start_date":"2026-08-18","completion_date":"2027-10-18","has_results":false,"results_due":false,"sponsor_name":"Bausch Health Americas, Inc.","sponsor_slug":"bausch-health-americas-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03876769","publication_url":"https://clinicaltrials.gov/study/NCT03876769","title":"A Phase II Trial of Tisagenlecleucel in First-line High-risk (HR) Pediatric and Young Adult Patients With B-cell Acute Lymphoblastic Leukemia (B-ALL) Who Are Minimal Residual Disease (MRD) Positive at the End of Consolidation (EOC) Therapy","has_exemption":false,"start_date":"2019-06-24","completion_date":"2027-10-19","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05118854","publication_url":"https://clinicaltrials.gov/study/NCT05118854","title":"A Phase II Study of Neoadjuvant Sotorasib in Combination With Cisplatin or Carboplatin and Pemetrexed for Surgically Resectable Stage IIA-IIIB Non-Squamous Non-Small Cell Lung Cancer With a KRAS p.G12C Mutation","has_exemption":false,"start_date":"2022-03-30","completion_date":"2027-10-20","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04011020","publication_url":"https://clinicaltrials.gov/study/NCT04011020","title":"Clinical Application of Stem Cell Educator Therapy in Type 1 Diabetes","has_exemption":false,"start_date":"2022-09-20","completion_date":"2027-10-20","has_results":false,"results_due":false,"sponsor_name":"Throne Biotechnologies Inc.","sponsor_slug":"throne-biotechnologies-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05545826","publication_url":"https://clinicaltrials.gov/study/NCT05545826","title":"Vibrotactile Coordinated Reset: A Treatment for Early Stage Parkinson's Disease","has_exemption":false,"start_date":"2025-04-01","completion_date":"2027-10-20","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06845319","publication_url":"https://clinicaltrials.gov/study/NCT06845319","title":"NeoCARD: A Response-Adapted Phase II Study of Anthracycline-Free Neoadjuvant Chemoimmunotherapy in Triple-Negative Breast Cancer Patients With Cardiomyopathy or Elevated Risk of Cardiotoxicity","has_exemption":false,"start_date":"2025-10-20","completion_date":"2027-10-20","has_results":false,"results_due":false,"sponsor_name":"Medical University of South Carolina","sponsor_slug":"medical-university-of-south-carolina","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07752407","publication_url":"https://clinicaltrials.gov/study/NCT07752407","title":"A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Vonoprazan 10 mg Compared to Placebo for Relief of Episodic Heartburn in Subjects With Symptomatic Non-Erosive Gastroesophageal Reflux Disease Through 24 Weeks","has_exemption":false,"start_date":"2026-09-25","completion_date":"2027-10-20","has_results":false,"results_due":false,"sponsor_name":"Phathom Pharmaceuticals, Inc.","sponsor_slug":"phathom-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05208307","publication_url":"https://clinicaltrials.gov/study/NCT05208307","title":"Maintenance Therapy With Belantamab, Pomalidomide and Dexamethasone (BPd) in High-Risk Myeloma Patients: A Phase 2 Study With a Safety Run-In","has_exemption":false,"start_date":"2022-07-21","completion_date":"2027-10-21","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02861573","publication_url":"https://clinicaltrials.gov/study/NCT02861573","title":"Phase Ib/II Trial of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (mCRPC) (KEYNOTE-365)","has_exemption":false,"start_date":"2016-11-17","completion_date":"2027-10-22","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT05805605","publication_url":"https://clinicaltrials.gov/study/NCT05805605","title":"Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning (RIC) With Post-Transplant Cytoxan (PTCy) for the Treatment of Hematological Diseases","has_exemption":false,"start_date":"2023-05-01","completion_date":"2027-10-22","has_results":false,"results_due":false,"sponsor_name":"Masonic Cancer Center, University of Minnesota","sponsor_slug":"masonic-cancer-center-university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06656390","publication_url":"https://clinicaltrials.gov/study/NCT06656390","title":"A First-in-Human, Open-Label, Multi-Center Phase I/II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of ALK201 for Injection in Adult Participants With Advanced Solid Tumors","has_exemption":false,"start_date":"2024-10-24","completion_date":"2027-10-22","has_results":false,"results_due":false,"sponsor_name":"Shanghai Allink Biotherapeutics Co., Ltd.","sponsor_slug":"shanghai-allink-biotherapeutics-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06824194","publication_url":"https://clinicaltrials.gov/study/NCT06824194","title":"A Phase 3, Randomized, Modified Double-blind, Active-controlled, Parallel-group, 2 Arm Study to Investigate the Safety of a 4-dose Regimen of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers","has_exemption":false,"start_date":"2025-02-18","completion_date":"2027-10-22","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06699849","publication_url":"https://clinicaltrials.gov/study/NCT06699849","title":"A Phase 2, Multicenter, Randomized, Multiple-Dose, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis","has_exemption":false,"start_date":"2025-07-10","completion_date":"2027-10-22","has_results":false,"results_due":false,"sponsor_name":"CSL Behring","sponsor_slug":"csl-behring","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02133196","publication_url":"https://clinicaltrials.gov/study/NCT02133196","title":"A Phase II Study Using Autologous Young Tumor-Infiltrating Lymphocytes Derived From Patients With Non-Small Cell Lung Cancer Following Non-Myeloablative Lymphocyte Depleting Preparative Regimen","has_exemption":false,"start_date":"2014-10-23","completion_date":"2027-10-23","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT05859334","publication_url":"https://clinicaltrials.gov/study/NCT05859334","title":"A Phase 2 Study of Erdafitinib in Patients With Recurrent or Progressive IDH-Wild Type Glioma With an FGFR-TACC Gene Fusion","has_exemption":false,"start_date":"2024-01-04","completion_date":"2027-10-23","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05012371","publication_url":"https://clinicaltrials.gov/study/NCT05012371","title":"A Phase II Study of Lenvatinib Plus Everolimus Versus Cabozantinib in Patients With Metastatic Renal Cell Carcinoma That Progressed on A PD-1/PD-L1 Checkpoint Inhibitor","has_exemption":false,"start_date":"2022-02-16","completion_date":"2027-10-25","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06966453","publication_url":"https://clinicaltrials.gov/study/NCT06966453","title":"A PHASE 1B/2, OPEN-LABEL, MULTICOHORT STUDY OF DISITAMAB VEDOTIN IN ADULTS WITH HER2 EXPRESSING ADVANCED BREAST CANCER","has_exemption":false,"start_date":"2025-06-30","completion_date":"2027-10-25","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06941870","publication_url":"https://clinicaltrials.gov/study/NCT06941870","title":"Prospective Interventional Study of Effectiveness of Efanesoctocog Alfa Prophylaxis on Synovial Hypertrophy in Patients With Hemophilia A","has_exemption":false,"start_date":"2025-09-23","completion_date":"2027-10-25","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07403487","publication_url":"https://clinicaltrials.gov/study/NCT07403487","title":"A Randomized, Double-blind, Placebo-controlled Phase II Clinical Trial to Evaluate the Efficacy and Safety of RC1416 Injection in Adult Patients With Moderate to Severe Asthma","has_exemption":false,"start_date":"2026-03-10","completion_date":"2027-10-25","has_results":false,"results_due":false,"sponsor_name":"Nanjing RegeneCore Biotech Co., Ltd.","sponsor_slug":"nanjing-regenecore-biotech-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03326336","publication_url":"https://clinicaltrials.gov/study/NCT03326336","title":"A Phase 1/2a, Open-Label, Non-Randomized, Dose-Escalation Study to Evaluate the Safety and Tolerability of GS030 in Subjects With Retinitis Pigmentosa","has_exemption":false,"start_date":"2018-09-26","completion_date":"2027-10-26","has_results":false,"results_due":false,"sponsor_name":"GenSight Biologics","sponsor_slug":"gensight-biologics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06435312","publication_url":"https://clinicaltrials.gov/study/NCT06435312","title":"An Open-Label Extension Study to Evaluate the Long-Term Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Activity of Zilucoplan in Pediatric Study Participants With Acetylcholine Receptor Antibody Positive Generalized Myasthenia Gravis","has_exemption":false,"start_date":"2024-11-19","completion_date":"2027-10-26","has_results":false,"results_due":false,"sponsor_name":"UCB Biopharma SRL","sponsor_slug":"ucb-biopharma-srl","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06990880","publication_url":"https://clinicaltrials.gov/study/NCT06990880","title":"A Phase 1/2 First-Time-in-Human, Open-label, Multicenter, Dose Escalation and Expansion Study of GSK5458514 PSMA Targeting T Cell Engager Alone or in Combination With Other Anti-cancer Agents in Adult Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC)","has_exemption":false,"start_date":"2025-06-12","completion_date":"2027-10-26","has_results":false,"results_due":false,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07166952","publication_url":"https://clinicaltrials.gov/study/NCT07166952","title":"Peripheral Nerve Stimulation With the SPRINT® System in Chronic Posterior Sacroiliac Joint Complex Pain","has_exemption":false,"start_date":"2025-10-26","completion_date":"2027-10-26","has_results":false,"results_due":false,"sponsor_name":"Medical University of South Carolina","sponsor_slug":"medical-university-of-south-carolina","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05923073","publication_url":"https://clinicaltrials.gov/study/NCT05923073","title":"A Phase 3, Multicenter, Randomized, Platform Study of p19 Inhibition of the IL-23 Pathway to Establish Efficacy in Pediatric Crohn's Disease","has_exemption":false,"start_date":"2024-03-13","completion_date":"2027-10-27","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07223645","publication_url":"https://clinicaltrials.gov/study/NCT07223645","title":"Handgrip Training and Brain Blood Flow Regulation","has_exemption":false,"start_date":"2025-10-27","completion_date":"2027-10-27","has_results":false,"results_due":false,"sponsor_name":"Florida State University","sponsor_slug":"florida-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04624204","publication_url":"https://clinicaltrials.gov/study/NCT04624204","title":"A Randomized, Double-blind, Placebo-controlled Phase 3 Study of Pembrolizumab (MK-3475) in Combination With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib (MK-7339), Compared to Concurrent Chemoradiation Therapy Alone in Participants With Newly Diagnosed Treatment-Naïve Limited-Stage Small Cell Lung Cancer (LS-SCLC)","has_exemption":false,"start_date":"2020-12-08","completion_date":"2027-10-28","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05672108","publication_url":"https://clinicaltrials.gov/study/NCT05672108","title":"Phase II Trial of Lung Chemoemobolization","has_exemption":false,"start_date":"2023-05-12","completion_date":"2027-10-28","has_results":false,"results_due":false,"sponsor_name":"City of Hope Medical Center","sponsor_slug":"city-of-hope-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06090539","publication_url":"https://clinicaltrials.gov/study/NCT06090539","title":"A Phase 1/2, Multi-Center, Open-Label, Dose-Finding Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of BMS-986458, Alone and in Combination With Anti-lymphoma Agents in Participants With Relapsed/Refractory Non-Hodgkin Lymphomas (R/R NHL)","has_exemption":false,"start_date":"2023-12-29","completion_date":"2027-10-28","has_results":false,"results_due":false,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06293053","publication_url":"https://clinicaltrials.gov/study/NCT06293053","title":"A Multicenter Open-label Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participants ≥6 Months to <18 Years of Age With Prurigo Nodularis","has_exemption":false,"start_date":"2024-05-15","completion_date":"2027-10-28","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06452277","publication_url":"https://clinicaltrials.gov/study/NCT06452277","title":"A Phase 3 Open-label, Randomized, Active-controlled, Multicenter Trial to Evaluate the Efficacy and Safety of Orally Administered BAY 2927088 Compared With Standard of Care as a First-line Therapy in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With HER2-activating Mutations","has_exemption":false,"start_date":"2024-08-28","completion_date":"2027-10-28","has_results":false,"results_due":false,"sponsor_name":"Bayer","sponsor_slug":"bayer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06959771","publication_url":"https://clinicaltrials.gov/study/NCT06959771","title":"Base Editing Hematopoietic Stem Cell and BE T Cell Gene Therapy for CD40L-HyperIgM Syndrome-Single Patient Study","has_exemption":false,"start_date":"2025-07-16","completion_date":"2027-10-28","has_results":false,"results_due":false,"sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","sponsor_slug":"national-institute-of-allergy-and-infectious-diseases-niaid","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07463183","publication_url":"https://clinicaltrials.gov/study/NCT07463183","title":"A Phase 2a Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of MK-8690 in Adult Participants With Moderately to Severely Active Ulcerative Colitis","has_exemption":false,"start_date":"2026-03-24","completion_date":"2027-10-28","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02843945","publication_url":"https://clinicaltrials.gov/study/NCT02843945","title":"Initial Feasibility Study to Evaluate the Safety and Efficacy of the Permanently Implantable LDR CivaSheet® in Combination With External Beam Radiation in the Treatment of Pancreatic Cancer","has_exemption":false,"start_date":"2017-05-31","completion_date":"2027-10-29","has_results":false,"results_due":false,"sponsor_name":"CivaTech Oncology","sponsor_slug":"civatech-oncology","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05334368","publication_url":"https://clinicaltrials.gov/study/NCT05334368","title":"A Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of Depemokimab in Adults With Hypereosinophilic Syndrome (HES)","has_exemption":false,"start_date":"2022-09-06","completion_date":"2027-10-29","has_results":false,"results_due":false,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05584124","publication_url":"https://clinicaltrials.gov/study/NCT05584124","title":"Neuromodulation for Rehabilitation of Post-Stroke Fatigue: An rTMS Pilot Study","has_exemption":false,"start_date":"2023-04-10","completion_date":"2027-10-29","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06117254","publication_url":"https://clinicaltrials.gov/study/NCT06117254","title":"Evaluating Device-based Rehabilitation for Veterans With Functional Hearing Difficulties: A Randomized Controlled Trial","has_exemption":false,"start_date":"2025-03-09","completion_date":"2027-10-29","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06680661","publication_url":"https://clinicaltrials.gov/study/NCT06680661","title":"ABBA CORD: Double Umbilical Cord Blood Transplants With Abatacept for Graft Versus Host Disease Prophylaxis","has_exemption":false,"start_date":"2026-04-08","completion_date":"2027-10-29","has_results":false,"results_due":false,"sponsor_name":"Leland Metheny","sponsor_slug":"leland-metheny","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07547436","publication_url":"https://clinicaltrials.gov/study/NCT07547436","title":"A Randomized, Double-blinded, Placebo-controlled, Parallel Group, Phase 2a Study to Assess the Activity, Safety, and Tolerability of SAR445399 in Adult Participants With Non-Cystic Fibrosis Bronchiectasis (NCFB)","has_exemption":false,"start_date":"2026-06-08","completion_date":"2027-10-29","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02484404","publication_url":"https://clinicaltrials.gov/study/NCT02484404","title":"Phase I/II Study of the Anti-Programmed Death Ligand-1 Antibody Durvalumab (MEDI4736) in Combination With Olaparib and/or Cediranib for Advanced Solid Tumors and Advanced or Recurrent Ovarian, Triple Negative Breast, Lung, Prostate and Colorectal Cancers","has_exemption":false,"start_date":"2015-06-29","completion_date":"2027-10-30","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03763162","publication_url":"https://clinicaltrials.gov/study/NCT03763162","title":"A Phase 2 Study of Daratumumab, Bortezomib, and Dexamethasone (DVd), Followed by Daratumumab, Ixazomib, and Dexamethasone (DId) for Relapsed and/or Refractory Myeloma","has_exemption":false,"start_date":"2019-01-17","completion_date":"2027-10-30","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04565665","publication_url":"https://clinicaltrials.gov/study/NCT04565665","title":"Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia","has_exemption":false,"start_date":"2020-07-29","completion_date":"2027-10-30","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05018286","publication_url":"https://clinicaltrials.gov/study/NCT05018286","title":"An Open-label Extension Trial to Evaluate the Long-term Safety of Apraglutide in Short Bowel Syndrome.","has_exemption":false,"start_date":"2021-07-13","completion_date":"2027-10-30","has_results":false,"results_due":false,"sponsor_name":"VectivBio AG","sponsor_slug":"vectivbio-ag","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04940286","publication_url":"https://clinicaltrials.gov/study/NCT04940286","title":"Phase II Study of Neoadjuvant Gemcitabine, Nab-paclitaxel, Durvalumab (MEDI4736) (Anti-PD-L1), and Oleclumab (Anti-CD73) in the Treatment of Resectable/Borderline Resectable Primary Pancreatic Adenocarcinoma","has_exemption":false,"start_date":"2021-09-28","completion_date":"2027-10-30","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05275972","publication_url":"https://clinicaltrials.gov/study/NCT05275972","title":"Descemet Endothelial Thickness Comparison Trials (DETECT I & II)","has_exemption":false,"start_date":"2023-01-23","completion_date":"2027-10-30","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05663710","publication_url":"https://clinicaltrials.gov/study/NCT05663710","title":"Phase 1b/2 Study of Combination 177Lu Girentuximab Plus Cabozantinib and Nivolumab in Treatment naïve Patients With Advanced Clear Cell RCC","has_exemption":false,"start_date":"2023-06-30","completion_date":"2027-10-30","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05949008","publication_url":"https://clinicaltrials.gov/study/NCT05949008","title":"Effect of Metformin ER With Hypocaloric Diet on Weight Loss in Overweight/Obese Patients With Increased Waist Circumference","has_exemption":false,"start_date":"2023-11-22","completion_date":"2027-10-30","has_results":false,"results_due":false,"sponsor_name":"University of California, Los Angeles","sponsor_slug":"university-of-california-los-angeles","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05922904","publication_url":"https://clinicaltrials.gov/study/NCT05922904","title":"PET Adapted Brentuximab Vedotin and Pembrolizumab in Combination With Doxorubicin and Dacarbazine in Classic Hodgkin Lymphoma","has_exemption":false,"start_date":"2023-12-14","completion_date":"2027-10-30","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05970172","publication_url":"https://clinicaltrials.gov/study/NCT05970172","title":"A Phase 3, Open-label, Uncontrolled Study to Evaluate the Activity, Safety, Pharmacokinetics and Pharmacodynamics of Roxadustat for the Treatment of Anemia in Pediatric Participants With Chronic Kidney Disease","has_exemption":false,"start_date":"2024-01-16","completion_date":"2027-10-30","has_results":false,"results_due":false,"sponsor_name":"Astellas Pharma Global Development, Inc.","sponsor_slug":"astellas-pharma-global-development-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06095505","publication_url":"https://clinicaltrials.gov/study/NCT06095505","title":"A Phase 2 Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer","has_exemption":false,"start_date":"2024-02-08","completion_date":"2027-10-30","has_results":false,"results_due":false,"sponsor_name":"Puma Biotechnology, Inc.","sponsor_slug":"puma-biotechnology-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05945355","publication_url":"https://clinicaltrials.gov/study/NCT05945355","title":"Mechanistic Study of Inspiratory Training in Childhood Asthma (MICA)","has_exemption":false,"start_date":"2024-08-01","completion_date":"2027-10-30","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06220474","publication_url":"https://clinicaltrials.gov/study/NCT06220474","title":"Therapeutic Efficacy and Safety of Non-Invasive Radiofrequency Treatment in Patients With Refractory Meibomian Gland Dysfunction: A Randomized Controlled Trial","has_exemption":false,"start_date":"2024-10-22","completion_date":"2027-10-30","has_results":false,"results_due":false,"sponsor_name":"The University of Hong Kong","sponsor_slug":"the-university-of-hong-kong","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06686108","publication_url":"https://clinicaltrials.gov/study/NCT06686108","title":"Safety and Efficacy Study of Demethylating Agents With Venetoclax in Preventing Recurrence of High-risk T-cell Lymphoblastic Lymphoma/Leukemia After Transplantation","has_exemption":false,"start_date":"2024-10-30","completion_date":"2027-10-30","has_results":false,"results_due":false,"sponsor_name":"Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine","sponsor_slug":"shanghai-general-hospital-shanghai-jiao-tong-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06718686","publication_url":"https://clinicaltrials.gov/study/NCT06718686","title":"Rifaximin in Dementia Trial (RIDE): Gut-Brain Modulation With Rifaximin SSD in Dementia","has_exemption":false,"start_date":"2024-12-30","completion_date":"2027-10-30","has_results":false,"results_due":false,"sponsor_name":"Jasmohan Bajaj","sponsor_slug":"jasmohan-bajaj","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06861439","publication_url":"https://clinicaltrials.gov/study/NCT06861439","title":"Effects of Tirzepatide on Fat-Free Mass, Bone and Physical Function in Older Adults - a Pilot Study","has_exemption":false,"start_date":"2025-07-07","completion_date":"2027-10-30","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07043400","publication_url":"https://clinicaltrials.gov/study/NCT07043400","title":"A Phase 3, Multi-Center, Randomized, Open-Label Clinical Study of Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy as First-Line Treatment in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma","has_exemption":false,"start_date":"2025-08-27","completion_date":"2027-10-30","has_results":false,"results_due":false,"sponsor_name":"BeOne Medicines","sponsor_slug":"beone-medicines","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07076082","publication_url":"https://clinicaltrials.gov/study/NCT07076082","title":"Vascular Trial Associated Registry Pilot: Antiplatelet Therapies for Patients Undergoing Lower Extremity Endovascular Revascularization","has_exemption":false,"start_date":"2025-10-15","completion_date":"2027-10-30","has_results":false,"results_due":false,"sponsor_name":"Corewell Health West","sponsor_slug":"corewell-health-west","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06967558","publication_url":"https://clinicaltrials.gov/study/NCT06967558","title":"The Role of Islet GLP-1 in the Pathogenesis of Prediabetes","has_exemption":false,"start_date":"2025-11-01","completion_date":"2027-10-30","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07466745","publication_url":"https://clinicaltrials.gov/study/NCT07466745","title":"Autus Size-Adjustable Valve for Surgical Pulmonary Valve Replacement Continued Access Study","has_exemption":false,"start_date":"2026-07-27","completion_date":"2027-10-30","has_results":false,"results_due":false,"sponsor_name":"Edwards Lifesciences","sponsor_slug":"edwards-lifesciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07032311","publication_url":"https://clinicaltrials.gov/study/NCT07032311","title":"Effect of Behavioral Intervention/Therapy to Reduce Diabetes and Liver Disease Risk Through Prescribed Digital Therapeutics Enabled by AI/ML Powered Predictive Analytics","has_exemption":false,"start_date":"2026-08-20","completion_date":"2027-10-30","has_results":false,"results_due":false,"sponsor_name":"SIPPA Solutions INC","sponsor_slug":"sippa-solutions-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07285616","publication_url":"https://clinicaltrials.gov/study/NCT07285616","title":"Optimizing Graft Selection in Glaucoma Surgery","has_exemption":false,"start_date":"2026-09-15","completion_date":"2027-10-30","has_results":false,"results_due":false,"sponsor_name":"University of Alberta","sponsor_slug":"university-of-alberta","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07871968","publication_url":"https://clinicaltrials.gov/study/NCT07871968","title":"Multicenter, Randomized, Open-label, Active-controlled Study With a Blinded Assessor to Evaluate the Safety and Tolerability of Pivmecillinam Hydrochloride Versus Nitrofurantoin for the Treatment of Female Pediatric Subjects, 12 Years to Less Than 18 Years of Age, With Uncomplicated Urinary Tract Infections","has_exemption":false,"start_date":"2026-10-24","completion_date":"2027-10-30","has_results":false,"results_due":false,"sponsor_name":"Alembic Therapeutics","sponsor_slug":"alembic-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07871630","publication_url":"https://clinicaltrials.gov/study/NCT07871630","title":"Phasix Mesh Underlay During Loop Ileostomy Closure: A Single Center Prospective Trial","has_exemption":false,"start_date":"2026-10-30","completion_date":"2027-10-30","has_results":false,"results_due":false,"sponsor_name":"Corewell Health West","sponsor_slug":"corewell-health-west","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT00077285","publication_url":"https://clinicaltrials.gov/study/NCT00077285","title":"A Pilot Phase II Trial Of Irinotecan Plus Carboplatin, And Irinotecan Maintenance Therapy (High-Risk Patients Only), Integrated Into The Upfront Therapy Of Newly Diagnosed Patients With Intermediate - And High-Risk Rhabdomyosarcoma","has_exemption":false,"start_date":"2003-10-31","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT00869232","publication_url":"https://clinicaltrials.gov/study/NCT00869232","title":"UARK 2008-02, A Phase II Trial for High-risk Myeloma Evaluation Accelerating and Sustaining Complete Remission (AS-CR) by Applying Non-host-exhausting and Timely Dose-reduced MEL-80-VRD-PACE Tandem Transplants","has_exemption":false,"start_date":"2008-10-31","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"University of Arkansas","sponsor_slug":"university-of-arkansas","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01208389","publication_url":"https://clinicaltrials.gov/study/NCT01208389","title":"A Follow-On Study to Evaluate the Safety of Re-Administration of Adeno-Associated Viral Vector Containing the Gene for Human RPE65 [AAV2-hRPE65v2] to the Contralateral Eye in Subjects With Leber Congenital Amaurosis (LCA) Previously Enrolled in a Phase 1 Study","has_exemption":false,"start_date":"2010-11-30","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Spark Therapeutics, Inc.","sponsor_slug":"spark-therapeutics-inc","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01424982","publication_url":"https://clinicaltrials.gov/study/NCT01424982","title":"Phase II Study of Combination of Hyper-CVAD and Ponatinib in Patients With Philadelphia (PH) Chromosome Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia (ALL)","has_exemption":false,"start_date":"2011-10-05","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01696734","publication_url":"https://clinicaltrials.gov/study/NCT01696734","title":"Treatment Protocol for the Compassionate Use of Domperidone","has_exemption":false,"start_date":"2012-10-23","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01720836","publication_url":"https://clinicaltrials.gov/study/NCT01720836","title":"Study of the Immunogenicity of the MUC1 Peptide - Poly-ICLC (Polyinosinic-polycytidylic Acid Stabilized With Polylysine and Carboxymethylcellulose) OR HILTONOL™ Adjuvant Vaccine in Patients With Localized and Locally Advanced Non-Small Cell Lung Cancer","has_exemption":false,"start_date":"2012-11-30","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Olivera Finn","sponsor_slug":"olivera-finn","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02043691","publication_url":"https://clinicaltrials.gov/study/NCT02043691","title":"Evaluation of All-Cause Mortality and Pulmonary Morbidity in Treating Juxtarenal, Suprarenal, Thoracoabdominal, and Aortic Arch Pathologies Using Cook Custom Aortic Endografts, the Zenith t-Branch Endovascular Graft, and the Surgeon-Modified Endograft","has_exemption":false,"start_date":"2014-06-30","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"University of Alabama at Birmingham","sponsor_slug":"university-of-alabama-at-birmingham","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02250937","publication_url":"https://clinicaltrials.gov/study/NCT02250937","title":"Allogeneic Transplantation Using Venetoclax, Timed Sequential Busulfan,Cladribine, and Fludarabine Conditioning in Patients With AML and MDS","has_exemption":false,"start_date":"2014-10-27","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02876107","publication_url":"https://clinicaltrials.gov/study/NCT02876107","title":"A Randomized Phase II Study of Neoadjuvant Carboplatin/Paclitaxel (CT) Versus Panitumumab/Carboplatin/Paclitaxel (PaCT) Followed by Anthracycline-Containing Regimen for Newly Diagnosed Primary Triple-Negative Inflammatory Breast Cancer","has_exemption":false,"start_date":"2016-10-06","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03141684","publication_url":"https://clinicaltrials.gov/study/NCT03141684","title":"A Phase 2 Study of Anti-PD-L1 Antibody (Atezolizumab) in Alveolar Soft Part Sarcoma","has_exemption":false,"start_date":"2017-04-25","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03004287","publication_url":"https://clinicaltrials.gov/study/NCT03004287","title":"2015-12: A Phase II Study Exploring the Use of Early and Late Consolidation/Maintenance With Anti-CD38 (Protein) Monoclonal Antibody to Improve Progression Free Survival in Patients With Newly Diagnosed Multiple Myeloma","has_exemption":false,"start_date":"2017-07-01","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"University of Arkansas","sponsor_slug":"university-of-arkansas","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03307616","publication_url":"https://clinicaltrials.gov/study/NCT03307616","title":"Phase II Study of Neoadjuvant Checkpoint Blockade in Patients With Surgically Resectable Undifferentiated Pleomorphic Sarcoma and Dedifferentiated Liposarcoma","has_exemption":false,"start_date":"2017-10-04","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03359954","publication_url":"https://clinicaltrials.gov/study/NCT03359954","title":"PRECISE: Preoperative Radiotherapy to Elicit Critical Immune Stimulating Effects","has_exemption":false,"start_date":"2017-11-16","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03716167","publication_url":"https://clinicaltrials.gov/study/NCT03716167","title":"Randomized Controlled Trial for Treatment of Pain and Assessment of Wound Healing in Chronic Venous Leg Ulcers","has_exemption":false,"start_date":"2018-07-27","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03693014","publication_url":"https://clinicaltrials.gov/study/NCT03693014","title":"A Phase II Trial of Hypofractionated Radiotherapy in Patients With Limited Progression on Immune Checkpoint Blockade","has_exemption":false,"start_date":"2018-10-01","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03607890","publication_url":"https://clinicaltrials.gov/study/NCT03607890","title":"Phase 2 Study of Nivolumab and Relatlimab in Advanced Mismatch Repair Deficient Cancers Resistant to Prior PD-(L)1 Inhibitor","has_exemption":false,"start_date":"2018-11-16","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","sponsor_slug":"sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04040062","publication_url":"https://clinicaltrials.gov/study/NCT04040062","title":"Pilot Study: Evaluating the Feasibility of Repetitive Transcranial Magnetic Stimulation Treatment Delivered at Individual-based, SCC-determined Frequency in Subjects Suffering From Major Depressive Disorder","has_exemption":false,"start_date":"2019-06-25","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"University of California, Los Angeles","sponsor_slug":"university-of-california-los-angeles","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03915431","publication_url":"https://clinicaltrials.gov/study/NCT03915431","title":"A Phase 1/2 Randomized Study to Evaluate the Safety and Tolerability of Intracarotid Artery Administration of NCS-01 in Patients With Acute Ischemic Stroke","has_exemption":false,"start_date":"2020-02-27","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"NC Medial Research Inc","sponsor_slug":"nc-medial-research-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04563507","publication_url":"https://clinicaltrials.gov/study/NCT04563507","title":"CIMER: Combined Immunotherapies in Metastatic ER+ Breast Cancer","has_exemption":false,"start_date":"2020-11-12","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Weill Medical College of Cornell University","sponsor_slug":"weill-medical-college-of-cornell-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04570423","publication_url":"https://clinicaltrials.gov/study/NCT04570423","title":"A Multicenter, Open-Label, Phase 2 Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Patients With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy","has_exemption":false,"start_date":"2021-05-20","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Spectrum Pharmaceuticals, Inc","sponsor_slug":"spectrum-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04858334","publication_url":"https://clinicaltrials.gov/study/NCT04858334","title":"APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation","has_exemption":false,"start_date":"2021-06-22","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04946370","publication_url":"https://clinicaltrials.gov/study/NCT04946370","title":"Phase I/II Trial of Pembrolizumab and Androgen-receptor Inhibitor With or Without 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate Cancer","has_exemption":false,"start_date":"2021-08-12","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Weill Medical College of Cornell University","sponsor_slug":"weill-medical-college-of-cornell-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04851717","publication_url":"https://clinicaltrials.gov/study/NCT04851717","title":"A Phase 2/3, Prospective, Open-label Trial Evaluating the Efficacy, Safety, and Pharmacokinetics of Remimazolam for Intravenous Sedation in Paediatric Patients Undergoing Diagnostic and/or Therapeutic Procedures","has_exemption":false,"start_date":"2021-11-15","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Acacia Pharma Ltd","sponsor_slug":"acacia-pharma-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04812925","publication_url":"https://clinicaltrials.gov/study/NCT04812925","title":"A Phase 3, Multicenter, Open-Label, Long-Term Trial to Evaluate the Safety and Efficacy of Efgartigimod (ARGX-113) PH20 Subcutaneous in Adult Patients With Primary Immune Thrombocytopenia","has_exemption":false,"start_date":"2021-11-17","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"argenx","sponsor_slug":"argenx","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04852328","publication_url":"https://clinicaltrials.gov/study/NCT04852328","title":"Non-Randomized Phase 2 Trial of Three Schedules of CUE-101 Administered Before Surgery or Definitive Chemoradiation Therapy in HLA-A*0201 Positive Patients With Locally Advanced, HPV16-Positive Oropharyngeal Squamous-Cell Carcinoma","has_exemption":false,"start_date":"2021-12-06","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05090722","publication_url":"https://clinicaltrials.gov/study/NCT05090722","title":"A Pilot Study to Evaluate PureWick for Nocturia","has_exemption":false,"start_date":"2021-12-16","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Northwell Health","sponsor_slug":"northwell-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04573023","publication_url":"https://clinicaltrials.gov/study/NCT04573023","title":"A Phase III Study of JR-141 in Patients With Mucopolysaccharidosis II (STARLIGHT)","has_exemption":false,"start_date":"2022-02-14","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"JCR Pharmaceuticals Co., Ltd.","sponsor_slug":"jcr-pharmaceuticals-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04566991","publication_url":"https://clinicaltrials.gov/study/NCT04566991","title":"Deferoxamine In the Treatment of Aneurysmal Subarachnoid Hemorrhage (DISH)","has_exemption":false,"start_date":"2022-03-20","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Aditya S. Pandey, MD","sponsor_slug":"aditya-s-pandey-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04741646","publication_url":"https://clinicaltrials.gov/study/NCT04741646","title":"Phosphate Binder Therapy and Chronic Kidney Disease in Children","has_exemption":false,"start_date":"2022-06-17","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"University of California, Los Angeles","sponsor_slug":"university-of-california-los-angeles","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05312671","publication_url":"https://clinicaltrials.gov/study/NCT05312671","title":"Atezolizumab With Platinum and Etoposide Chemotherapy Followed by Cystectomy for Patients With Localized Small Cell Neuroendocrine Bladder Cancer","has_exemption":false,"start_date":"2022-06-27","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","sponsor_slug":"sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05301816","publication_url":"https://clinicaltrials.gov/study/NCT05301816","title":"A Post-Market, Multicenter, Prospective, Global Clinical Study to Evaluate the Real-world Experience of Spinal Cord Stimulation That Includes 10 kHz in the Management of Chronic Intractable Pain Associated With Diabetic Neuropathy.","has_exemption":false,"start_date":"2022-07-05","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Nevro Corp","sponsor_slug":"nevro-corp","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05353647","publication_url":"https://clinicaltrials.gov/study/NCT05353647","title":"A Multi-Center, Phase 2 Gene Transfer Study Inducing Fetal Hemoglobin in Sickle Cell (GRASP, BMT CTN 2001)","has_exemption":false,"start_date":"2022-07-12","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"David Williams","sponsor_slug":"david-williams","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05254743","publication_url":"https://clinicaltrials.gov/study/NCT05254743","title":"A Phase 3 Open-Label, Randomized Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN-CLL-314)","has_exemption":false,"start_date":"2022-07-22","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Loxo Oncology, Inc.","sponsor_slug":"loxo-oncology-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05384535","publication_url":"https://clinicaltrials.gov/study/NCT05384535","title":"Utility of Biparametric MRI (Magnetic Resonance Imaging) as a Screening Tool for Prostate Cancer in a High-Risk Cohort","has_exemption":false,"start_date":"2022-08-15","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Northwell Health","sponsor_slug":"northwell-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05570253","publication_url":"https://clinicaltrials.gov/study/NCT05570253","title":"\"A Phase 2, Double Blinded, Randomized Controlled Trial of Evexomostat (SDX-7320) or Placebo in Combination With Eribulin for Patients With Metastatic Triple-Negative Breast Cancer and Metabolic Dysfunction: The ARETHA Study","has_exemption":false,"start_date":"2022-10-03","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05514054","publication_url":"https://clinicaltrials.gov/study/NCT05514054","title":"EMBER-4: A Randomized, Open-Label, Phase 3 Study of Adjuvant Imlunestrant vs Standard Adjuvant Endocrine Therapy in Patients Who Have Previously Received 2 to 5 Years of Adjuvant Endocrine Therapy for ER+, HER2- Early Breast Cancer With an Increased Risk of Recurrence","has_exemption":false,"start_date":"2022-10-04","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05317806","publication_url":"https://clinicaltrials.gov/study/NCT05317806","title":"Use of Metformin in Prevention and Treatment of Cardiac Fibrosis in PAI-1 Deficient Population","has_exemption":false,"start_date":"2022-10-10","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Indiana Hemophilia &Thrombosis Center, Inc.","sponsor_slug":"indiana-hemophilia-thrombosis-center-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05556512","publication_url":"https://clinicaltrials.gov/study/NCT05556512","title":"A Phase 3, Randomized, Double-blind, Placebo-Controlled Study to Investigate the Effect of Tirzepatide on the Reduction of Morbidity and Mortality in Adults With Obesity","has_exemption":false,"start_date":"2022-10-11","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03887481","publication_url":"https://clinicaltrials.gov/study/NCT03887481","title":"Targeting Language-specific and Executive-control Networks With Transcranial Direct Current Stimulation in Aphasic AD (Logopenic Variant PPA)","has_exemption":false,"start_date":"2022-10-15","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05256225","publication_url":"https://clinicaltrials.gov/study/NCT05256225","title":"A Phase II/III Study of Paclitaxel/Carboplatin Alone or Combined With Either Trastuzumab and Hyaluronidase-oysk (HERCEPTIN HYLECTA) or Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf (PHESGO) in HER2 Positive, Stage I-IV Endometrial Serous Carcinoma or Carcinosarcoma","has_exemption":false,"start_date":"2022-11-16","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05492799","publication_url":"https://clinicaltrials.gov/study/NCT05492799","title":"Open-Label Multicenter Extension Study to Further Evaluate Safety, Tolerability and Efficacy of Intracerebroventricular AX 250 Treatment in Mucopolysaccharidosis Type IIIB (MPS IIIB, Sanfilippo Syndrome Type B) Patients","has_exemption":false,"start_date":"2022-12-02","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Allievex Corporation","sponsor_slug":"allievex-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05554172","publication_url":"https://clinicaltrials.gov/study/NCT05554172","title":"Efficacy of Non-invasive Vagus Nerve Stimulation for Treatment of Low Weight Eating Disorders","has_exemption":false,"start_date":"2022-12-13","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05650229","publication_url":"https://clinicaltrials.gov/study/NCT05650229","title":"An Interventional, Randomised, Double-blind, Parallel-group, Placebo-controlled, Flexible-dose, Adaptive Study of the Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease","has_exemption":false,"start_date":"2022-12-13","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Pharming Technologies B.V.","sponsor_slug":"pharming-technologies-bv","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05030545","publication_url":"https://clinicaltrials.gov/study/NCT05030545","title":"Cardiovascular Manifestations of MR Activation in Primary Aldosteronism: Pilot Clinical Study","has_exemption":false,"start_date":"2022-12-15","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05640947","publication_url":"https://clinicaltrials.gov/study/NCT05640947","title":"Endoscopic Ultrasound-guided Large Diameter Lumen-apposing Metal Stent Gastro-gastrostomy for Bypass Reversal in Patients With Roux-en-y Gastric Bypass: a Proof of Concent Study","has_exemption":false,"start_date":"2023-01-30","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"University Hospital, Ghent","sponsor_slug":"university-hospital-ghent","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05807399","publication_url":"https://clinicaltrials.gov/study/NCT05807399","title":"A Multiple-arm, Multiple-stage (MAMS), Phase 2B/C, Open-label, Randomized, Controlled Platform Trial to Evaluate Experimental Arms Including Optimised Use of Existing and Introduction of Novel Anti-tuberculosis Drugs, in Adults With Newly Diagnosed, Drug-sensitive, Smear-positive Pulmonary Tuberculosis","has_exemption":false,"start_date":"2023-04-14","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Michael Hoelscher","sponsor_slug":"michael-hoelscher","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05707377","publication_url":"https://clinicaltrials.gov/study/NCT05707377","title":"A Phase 2/3, Multicenter, Randomized, Active-Controlled, Open-label Study to Evaluate the Efficacy and Safety of Zanubrutinib in Patients With Primary Membranous Nephropathy","has_exemption":false,"start_date":"2023-04-17","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"BeOne Medicines","sponsor_slug":"beone-medicines","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05712057","publication_url":"https://clinicaltrials.gov/study/NCT05712057","title":"Neurostimulation Enhanced Cognitive Restructuring for Transdiagnostic Emotional Dysregulation: A Component Analysis","has_exemption":false,"start_date":"2023-05-15","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05907343","publication_url":"https://clinicaltrials.gov/study/NCT05907343","title":"Closed-Loop Brain Stimulation as a Potential Intervention for Cognitive Decline","has_exemption":false,"start_date":"2023-05-31","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"University of Texas at Austin","sponsor_slug":"university-of-texas-at-austin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06087458","publication_url":"https://clinicaltrials.gov/study/NCT06087458","title":"Phase 1/2a Study of VOY-101 in Subjects With Advanced Non-Neovascular Age-Related Macular Degeneration (JOURNEY)","has_exemption":false,"start_date":"2023-06-21","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Perceive Biotherapeutics, Inc.","sponsor_slug":"perceive-biotherapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05564598","publication_url":"https://clinicaltrials.gov/study/NCT05564598","title":"A Phase II Open-Label Randomized Study of Anti-Viral Antibiotic Therapy With and Without Familial (Maternal) Cytomegalovirus (CMV) Cytotoxic T Lymphocytes (CTLs) in Neonates With Moderate/Severe Maternal Acquired CMV Infection","has_exemption":false,"start_date":"2023-07-01","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"New York Medical College","sponsor_slug":"new-york-medical-college","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05721027","publication_url":"https://clinicaltrials.gov/study/NCT05721027","title":"Ibuprofen With or Without Dexamethasone for Acute Radicular Low Back Pain.","has_exemption":false,"start_date":"2023-07-05","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Montefiore Medical Center","sponsor_slug":"montefiore-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05901675","publication_url":"https://clinicaltrials.gov/study/NCT05901675","title":"Enhancing Mobility and Psychosocial Function in Obese Veterans Following Stroke Via Weight Loss and ExeRcise (EMPOWER)","has_exemption":false,"start_date":"2023-07-07","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Medical University of South Carolina","sponsor_slug":"medical-university-of-south-carolina","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05514899","publication_url":"https://clinicaltrials.gov/study/NCT05514899","title":"Effects of Cannabidiol and Tetrahydrocannabinol on the Microbiome, Endocannabinoids, and Neuroinflammation in HIV","has_exemption":false,"start_date":"2023-09-01","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05938543","publication_url":"https://clinicaltrials.gov/study/NCT05938543","title":"Noninvasive Neuromodulation of a Novel Cerebellar Satiety Circuit in Prader-Willi Syndrome","has_exemption":false,"start_date":"2023-09-01","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05693909","publication_url":"https://clinicaltrials.gov/study/NCT05693909","title":"An Open-label, Dose-escalation, Dose-finding, and Proof-of-concept Trial of SP-420 in Subjects With Transfusion-dependent β-thalassemia or Low-risk Myelodysplastic Syndromes","has_exemption":false,"start_date":"2023-09-04","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Pharmacosmos A/S","sponsor_slug":"pharmacosmos-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06066346","publication_url":"https://clinicaltrials.gov/study/NCT06066346","title":"Talquetamab Consolidation After BCMA CART Cell Therapy for Relapsed or Refractory Multiple Myeloma","has_exemption":false,"start_date":"2023-09-27","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06038578","publication_url":"https://clinicaltrials.gov/study/NCT06038578","title":"A Randomized, Multicenter, Open-Label, Phase 2 Study of TRK-950 When Used in Combination With Ramucirumab and Paclitaxel in Patients With Gastric Cancer","has_exemption":false,"start_date":"2023-10-04","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Toray Industries, Inc","sponsor_slug":"toray-industries-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06099769","publication_url":"https://clinicaltrials.gov/study/NCT06099769","title":"A RANDOMIZED, PHASE II STUDY OF ENZALUTAMIDE, ENZALUTAMIDE WITH MIFEPRISTONE, and TREATMENT OF PHYSICIAN'S CHOICE IN PATIENTS WITH AR+ METASTATIC TRIPLE-NEGATIVE OR ER-LOW BREAST CANCER","has_exemption":false,"start_date":"2023-10-18","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06041321","publication_url":"https://clinicaltrials.gov/study/NCT06041321","title":"The Effect of a Novel Bioactive Sleeve on Postoperative Pain and Patient Reported Outcome Scores After Arthroscopic Meniscectomy and Meniscus Repairs: A Randomized Placebo Controlled Study","has_exemption":false,"start_date":"2023-12-06","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Northwell Health","sponsor_slug":"northwell-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06244771","publication_url":"https://clinicaltrials.gov/study/NCT06244771","title":"An Open-Label, Phase 1/2 Dose Escalation, Dose Expansion and Cohort Expansion Study Evaluating the Safety, PK and Clinical Activity of FMC-376 Monotherapy and in Combination With Pembrolizumab in Participants With KRAS G12C Mutated Advanced Solid Tumors","has_exemption":false,"start_date":"2024-02-12","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Frontier Medicines Corporation","sponsor_slug":"frontier-medicines-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06149481","publication_url":"https://clinicaltrials.gov/study/NCT06149481","title":"Phase I/II Study of the Combination Immunotherapy Regimen: SX-682, TriAdeno Vaccine, Retifanlimab and IL-15 Agonist N-803 (STAR15) for Metastatic Colorectal Cancer (mCRC)","has_exemption":false,"start_date":"2024-03-26","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06026657","publication_url":"https://clinicaltrials.gov/study/NCT06026657","title":"Phase 1b/2 Study of Naxitamab (Danyelza), Gemcitabine and Ex Vivo Expanded Allogenic Universal Donor, TGFβi Natural Killer (NK) Cells in Advanced GD2-expressing Breast Cancers (DiG NKs)","has_exemption":false,"start_date":"2024-04-02","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Margaret Gatti-Mays","sponsor_slug":"margaret-gatti-mays","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06214065","publication_url":"https://clinicaltrials.gov/study/NCT06214065","title":"Modulating Temporoparietal Junction Mentalizing-Related Activity in Autism Spectrum Disorder Using Transcranial Magnetic Stimulation","has_exemption":false,"start_date":"2024-04-03","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06439277","publication_url":"https://clinicaltrials.gov/study/NCT06439277","title":"Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo for the Treatment of Obesity and Weight-Related Comorbidities in Adolescents: A Randomized, Double-Blind, Placebo- Controlled Trial (SURMOUNT-ADOLESCENTS-2)","has_exemption":false,"start_date":"2024-06-03","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06203600","publication_url":"https://clinicaltrials.gov/study/NCT06203600","title":"Randomized Phase II/III Trial of 2nd Line Nivolumab + Paclitaxel + Ramucirumab Versus Paclitaxel + Ramucirumab in Patients With PD-L1 CPS &gt;/= 1 Advanced Gastric and Esophageal Adenocarcinoma (PARAMUNE)","has_exemption":false,"start_date":"2024-06-24","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06569368","publication_url":"https://clinicaltrials.gov/study/NCT06569368","title":"A Phase II Trial Utilizing Metronidazole to Optimize the Microbiome of Rectal Adenocarcinoma Undergoing Neoadjuvant Therapy","has_exemption":false,"start_date":"2024-07-10","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06736860","publication_url":"https://clinicaltrials.gov/study/NCT06736860","title":"Early and Precise Application and Evaluation of Tranexamic Acid in Patients With Traumatic Bleeding Based on Dynamic Monitoring of Thromboelastography","has_exemption":false,"start_date":"2024-08-01","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Nanfang Hospital, Southern Medical University","sponsor_slug":"nanfang-hospital-southern-medical-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06523556","publication_url":"https://clinicaltrials.gov/study/NCT06523556","title":"Phase 1b/2 Study of Axatilimab (SNDX-6352) + Azacitidine (AZA) in Advanced Phase MPN, MPN/MDS Overlap or High-Risk CMML","has_exemption":false,"start_date":"2024-08-02","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Uma Borate","sponsor_slug":"uma-borate","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06268665","publication_url":"https://clinicaltrials.gov/study/NCT06268665","title":"A Randomized Trial of Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy","has_exemption":false,"start_date":"2024-08-15","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"University of California, Davis","sponsor_slug":"university-of-california-davis","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05839730","publication_url":"https://clinicaltrials.gov/study/NCT05839730","title":"Fast Induced Remodeling in Heart Failure With Preserved Ejection Fraction","has_exemption":false,"start_date":"2024-09-11","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Medtronic Cardiac Rhythm and Heart Failure","sponsor_slug":"medtronic-cardiac-rhythm-and-heart-failure","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06588413","publication_url":"https://clinicaltrials.gov/study/NCT06588413","title":"Randomized, Double-Blind Study of FOND (Fosaprepitant, ONdansetron, Dexamethasone) Plus Either Olanzapine 2.5 mg Versus 5 mg for the Prevention of Chemotherapy Induced Nausea and Vomiting in Patients Receiving High-dose Melphalan Conditioning: The FONDO-LOW Study","has_exemption":false,"start_date":"2024-09-17","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Augusta University","sponsor_slug":"augusta-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06458439","publication_url":"https://clinicaltrials.gov/study/NCT06458439","title":"Phase IIa Trial to Evaluate Epcoritamab Administered Before and After CAR-T Cell Therapy in Patients With Relapsed or Refractory Large B-cell Lymphomas","has_exemption":false,"start_date":"2024-09-24","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Abramson Cancer Center at Penn Medicine","sponsor_slug":"abramson-cancer-center-at-penn-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06625060","publication_url":"https://clinicaltrials.gov/study/NCT06625060","title":"A Multicentre, Randomised, Double-blind, Placebo-controlled, Dose Escalation and Dose Finding Phase II Study to Evaluate the Safety and Efficacy of IPN10200 in the Prevention of Episodic or Chronic Migraine in Adults","has_exemption":false,"start_date":"2024-10-10","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Ipsen","sponsor_slug":"ipsen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06643312","publication_url":"https://clinicaltrials.gov/study/NCT06643312","title":"Tethered Pelvic Assist Device for Recovery of Standing After Severe SCI","has_exemption":false,"start_date":"2024-10-22","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"Kessler Foundation","sponsor_slug":"kessler-foundation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06100172","publication_url":"https://clinicaltrials.gov/study/NCT06100172","title":"Delivering Transcutaneous Auricular Neurostimulation as an Adjunct Non-Opioid Pain Management Therapy for Patients Undergoing Lumbar Surgery","has_exemption":false,"start_date":"2024-10-29","completion_date":"2027-10-31","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null}]}